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1. INTRODUCTION 
 Siddha system of medicine is a form of traditional medicine which originated 
from south India.  It is the only medical system that is said to be bestow immortality.  
This system not only deals with medicine but with spirituality, righteous way of living, 
rejuvenation and its main aim is attainment of perfection. 
 The siddha system of medicine is one of the pillars of indian system of medicine.  
It is dedicate bequest of Siddhars. 
 Siddha system is the first system to emphasize health as a perfect state of physical, 
psychological, social and spiritual component of a human being.  This explanation is 
quoted in “Thirumanthiram” which is pioneer word by saint Thirumoolar as follows. 
 lXh<hKmz<!Ofib<!lVf<oke!ziGl<!
! lXh<h!KtOfib<!lVf<okes<!siZl<!
! lXh<hkqeq!Ofib<!uvikqVg<g!
! lXh<hK!siju!lVf<oke!ziOl”!
. kqVlf<kqvl</!
Siddha system that insist that the physician should enquire the nature of the 
disease, its cause and its method of cure and treat it faithfully Envagai Thaervugal (the 
eight methods of clinical examination) are used to determine the diagnosis aetiology 
treatment and prognosis of diseases. 
 Our unique system of Tamil medicine is based upon two main theories.  They are 
the Panchabootha theory and Mukkutra theory.  According to Panchabootha theory the 
universe is formed of five elements.  Namely, Pirithvi (Earth), Appu (water), Theyu (fire), 
vaayu (wind) and is formed of it in definite proportion.  
This is explained as thiruvalluvar as,  
 “fqzl<!fQI!kQutq!uqSl<!Ohijmf<Kl<!
! gzf<k!lbg<gl<!dzgl<!Nkzqe<!
! According to Mukkutra theory, the three vital humours namely vatham, pitham 
and kabam.  When in equilibrium keep the body in homeostasis but when vitiated either 
single or in combination bring about disease.  It is quoted by thiruvalluvar as follows,  
 “lqgqEl<!GjxbqEl<!Ofib<!osb<Bl<!F~OziI!
! utqLkzi!w{<{qb!&e<X”!
! In the present human era, many diseases threaten the life of human beings, due to 
the modern life style, food habits, etc.  Infectious diseases most commonly affects all age 
group peolpe from children to adults.  One of the most important common and infectious 
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disease is diarrhoea, which is compared to Bedhi in siddha literatures .  Bedhi is a disease 
of Gastro intestinal tract.  It is an infectious disease occurs due to poor sanitation.  The 
description of the disease is clearly depicted in Siddha Maruthuvam. 
 In siddha system of medicine, Bedhi is also known as Athisaram, kazhichal, 
kirahani. 
 As per literature evidence from, sikitcha rathna deepam yennum vaidhiya nool 
indicated for all types of Bedhi.  Hence I have selected my dessertation topic is 
KATTUVAI MATHIRAI to evaluate Anti-diarrhoeal, Anti-pyretic, Anti-spasmodic 
activities. 
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2. AIM AND OBJECTIVES 
AIM 
 The aim of this study is to do a scientific review to validate the safety and efficacy 
of “Kattuvai Mathirai” for Anti-diarrhoeal, Anti-pyretic  and Anti-spasmodic activities. 
 
OBJECTIVES 
 The main objective of the present study is to high light the safety and efficacy of 
Kattuvai Mathirai in the treatment of Bedhi, the following methodology was 
adopted to evaluate the drug and its standardization studies. 
 To collect the literature systematically from siddha texts as well as modern 
science. 
 To standardize the preparation of drug according to classical siddha literature. 
 To subject the drug to physico chemical and chemical analysis. 
 To detect the elements present in the drug by instrumental analysis. 
 To study the acute and subacute toxicity profile of Kattuvai Mathirai according to 
OECD 423 and 407 guidelines. 
 Evaluation of Anti-diarrhoeal activity of test drug. 
 Evaluation of Anti-pyretic activity of test drug 
 Evaluation of Anti-spasmodic activity of test drug 
 To analyse all the above study results to validate the advantage of Kattuvai  
Mathirai 
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3.REVIEW OF LITERATURE 
 
3.1. CINNABAR  - -zqr<gl<< << << <!
(Mercury sulphide) 
3.1.1.GUNAPADAM  ASPECT 
General character 
 “OhkqSvR<sf<fq!ohVuqv{!fQoviMk!
! gikgc!gisr<!gvh<hie<H{<!.O{ik!
! UVuqzqr<g!sr<gkli!B,Xgm<c!Bl<Ohir<!
! GVuqzqr<g!sr<glk<jkg<!ogit<”/!
! “Nkq!bqvkUg<!gikzix<!sikqzqr<g!
! Olikq!zqvkG{!Lx<X~mzqx<!.xQKHiq!
! Gm<mr<!gqvf<kq!ogiMR<$jz!uikLk!
! Zm<mr<!Ofib<gjtObim<!Ml</”!
!.!G{himl<!kiK!sQul<!
  It is effective in the treatment of diarrhoea, pyrexia, delirium, utricaria, diuresis, 
tuberculosis, scabies, unknown insect bites, syphilis, leprosy, eczema, skin diseases, 
throbbing pain (Soolai),  and vatha diseases. 
Synonyms 
  Aankuri, Inkuligam, Irraasam, Kadaivanni, Karppam, Kalikkam, Kaanjanam, 
Kaaranam, Saaniyam, Sandagam, Samarasam, Chendooram, Maniraagam, Milecham, 
Vani and Vanni. 
Vernacular Names: 
  Tamil   : Lingam 
 Eng   : Cinnabar 
 Tel   : Ingileekam 
 Canarose  : Inglika 
Malayal  :  Chayilyam 
Urudu   : Singraff 
Properties: 
  Colour   : Bright red colour 
 Appearance  : Red crystal 
 Potency  : Hot 
 Taste   : No taste 
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Action: 
  Antipyretic 
 Tonic 
 Anti diarrhoeal 
 Anti vaadha 
Method of Preparation: 
  Purified mercury : 280gm 
 Sulphur  : 70gm 
 Pottasium Nitrate : 70gm 
  Mercury is thoroughly mixed and triturated with sulphur. Pottasium nitrate is then 
added. Placed in a conical flask and burnt for 18 hours. After cooling, the red sulphide of 
mercury is collected out. 
  It is hard when it is put into fire it becomes smoke not soluble in water. It has no 
smell and taste and has not potency. It has properties of a tonic. This preparation is 
effective in the treatment of diarrhoea, Pyrexia 
Method of Purification: 
   Alangium bark (Alangium saulifolium) – 1400gm is powdered and added with 
vinegar is powdered and added with vinegar  5.2litres and placed indews in the night. The 
next day it is rubbed and mixed well  35gm of cinnabar is tied well in a cloth and put into 
the above liquid. The pot is covered with another pot sealed with mud pasted cloth, dried 
and exposed in dew for one day. It is heated with low intensity fire (Flame) until the 
liquid is dehydrated for 24 hours. Then the cinnabar is taken out and cleaned well . This 
procedure is repeated using the vinegar soaked individually with the whole plant of vitis 
lanata (pulikarunai) and Indian sarasaparilla root as stressed in the following Tamil 
verses. 
!!!“osiz<zg<!Ogt<!Hzk<kqbOe!lgOebqf<kf<!
! ! Kjxbie!sikqzqr<g!Sk<kqkiOe!
! ouz<zg<Og!zpqR<sqz<!Htqr<!gVj{ObiM!
! ! Olzie!fe<eiiqg<!gick<!k{<{Qi<!
! Hz<ze<!OgtkqOzii<!&e<X!jugz<!
! ! Hjgbilz<!uqtg<gqoziq!bLg<G!fQr<Gl<!
ouz<zg<Og!ttUokic!ogie<Ox!uqjs!
! ouXf<!k{<{Qi<!fiZhc!uQkliOl”!
!
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!
“Olgh<!hq{q!Lkz<!Ohiz!oue<xiz<!!
! Olzil!zqr<gl<!Sk<kq!osb<b!
ligk<!klqR<sq!gVj{!fiiq!
! uib<k<k!HtqfQ!ovie<hi!fit<!
higk<!kpoziq!kQuq!jgOhix<!
! hil<Hh<!hQmgi<!jgh<h{<!hqoke!
Ougljk!fQg<oge<!ximib<!hil<Oh!
! OlziR<!svg<gqoke<!fimib<!hil<Oh”!
 
Another method of purification : 
1. Lime juice, cow’s milk and the indian acalypha juice are mixed in equal 
proportion and allowed to fuse cinnabar so as to get it in a consolidated potency 
state 
2. When the crude form of red sulphide of mercury is soaked for one day in mother’s 
milk and lemon juice respectively it becomes purified. 
Le<Esikq!zqr<gf<!ke<je!
! Ljzh<hizq!z~xjuk<ok!
hqe<eV!fx<!sl<hQvk<kqe<!
! ohVr<geqs<!six<xqs<!Sk<kq!
!! Svg<GgTg<ogiz<zl<! -zqr<gl<! -jxobeUl<?! Olg! Ofib<gTg<G!
fle<Ohie<xokeUl<?!Hge<xqVh<hjk?!
  “-r<Gzqgs<!svg<ogie<Ox!svg<Gg<ogz<zi!lqjx!biGl<”!
! “Olgujg!uqjeg<G!fleie!zqr<gl<”!
! Okve<! lVk<Kuh<! hivkk<kqz<! nzX! sf<fqg<G! -zqr<gk<kqe<! Nm<sq!
%xh<hm<Mt<tK/!
!!  Lingam is the chief dominant among the all drugs as well as its effective in 
sexually transmitted diseases. 
Dosage 
 Internal - 650mg 
 External - 2.1gm 
 Reference - Baijasa kalpam 
3. Cinnabar is soaked in mother’s milk for 30 naazhigai (72 mins).  It is removed 
and again fresh milk is added  and the process is repeated above for 2 times. 
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LINGAM  IN OTHER MEDICINES: 
1. BAIRAVA MATHIRAI: 
  Dosage : Kundrimani alavu  (130mg) 
 Indications : Athisaram 
- Anuboga vaidhiya brahma ragashiyam – 339 
2. SANGUVADI MATHIRAI: 
  Dosage :  Kundrimani alavu  (130mg) 
 Indications : Kirakani 
- Anuboga vaidhiya brahma ragashiyam – 344 
3. PADIGA LINGA CHENDURAM: 
  Dosage :   3 – 5 Kundrimani alavu  (650mg) 
 Adjuvant : Ghee, Butter 
Indications : Seetha bedhi, Ratha bedhi, Oozhi 
4. SUYAMAKKINI KUMARAN CHENDOORAM: 
  Dosage :  Kundrimani alavu  (130mg) 
 Adjuvant : Honey 
 Indications : Kirani 
 
5. SANDA RASA PARPAM: 
  Dosage :  Panavedai  (488mg) 
 Adjuvant : Jaggery 
 Indications : Bedhi, Kirakani, Oozhi 
TOXIC SYMPTOMS OF LINGAM: 
   Loss of taste and difficulty in eating and drinking water. Ulcers which in the 
buccal floor.  Uvula(base of the mouth), inner portion of the tongue, larynx and large 
intestine, foul odor from the mouth, discharge of viscous, whitish saliva, difficult to speak 
and burning sensation  are the toxic features of a red sulphide of mercury. 
ANTIDOTE: 
  Nutmeg (Myristica fragrans), cubeb peper (Piper cubeba), root bark of a red 
cotton tree (Gossypium arboreum) and sugar candy each 4.2gm are made into a decoction 
and administered twice a day for 48 days. 
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CINNABAR 
3.1.2. GEOLOGICAL ASPECT  
Chemical Name 
 Natural  - Cinnabar 
 Synthetic - Vermilion 
Scientific Name 
 Mercuric sulphide (or) Mercuric II sulphide 
 Colour  - Cochineal-red toward brownish red and lead gray 
 Symbol - HgS 
Molecular formula 
 Molecular weight - 232.68 
 Hardness  - 2.5 
 Specific gravity - 8.176 
 Sublimes at  - 446 °C 
 Crystal systems - Hexagonal (or) Rhombohedral 
Character 
 Cinnabar is practically insoluble in water, not allowed by HNO3 or cold HCl, but 
decomposed by Con.H2So4  soluble in aquaregia with separation of sulphur and in warm 
HCl with evaluation of Hydrogen sulphate. 
Preparation of cinnabar at Laboratory 
 One part of the mercury and four parts of the sulphur and to be placed parts of the 
sulphur and to be placed in an iron pot and heated for sometimes.  The amalgam is then to 
be broken into pieces and put into a glass bottle, previously coated all round with mud 
and rag one inch deep and dried in shade.  The bottle is to be heated for five days 
continuously by means of the five increasing gradually intensity at a uniform rate.  The 
heating is then to be discontinued and the contents of the glass bottle taken out on the 
seventh day.  The product will be found to be cinnabar. 
History  
 Cinnabar commonly known as Lingam, Hingul, Shingara is fine red colour 
powder. 
 Alchemy is an art of refurination with using mercurial Indian alchemy probably 
being about 500 A.D. 
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 Mercury and cinnabar was known and used in Europe, China 100 years before the 
first mention is Indian medicinal works.  Chinese could properly select cinnabar as the 
best substitute of blood in colour.  This made cinnabar soul and its components sulphur 
and mercury sub souls.  Nothing better than cinnabar was found as equal to red colour.  
Cinnabar is a heavy native one mercury.  Extracted all over the world found in all 
countries, except Antartica. 
Occurance: 
 It is a mineral and important chief of mercury it occurs in minerable deposits in a 
very few localities, commonly found in veins and impregnation deposited near the surface 
of recent volcanic rocks and hot springs and most important deposits are Almaden and 
spine and it has been mined for more than 2500 years from these places. 
 Other localities are Idria, Italy/Kweichow, China and New Almaden, New Idria, 
California of USA.  It is also mined in Navadautah, Olegon Arkananas and Texas. 
Properties 
 Cinnabar exist in 2 modifications black and red.  Both occur in native,  artificially 
prepared cinnabar, however a vivid scarlet substances and is used as an artist pigment 
called ‘vermilion’. 
 The scarlet red variety occurs as lumps and in Hexagona α – form crystals 
  Colour   - Vermilion red 
  Hardness  - 2.5 
  Specific gravity - 8.10 
 The shortest distance HgS. is 2.52 A and the binding between mercury and 
sulphur probably ionic in character. 
Black merury sulphide (meta Cinnabar) (black Kubic β – form) 
  Colour   - grayish black 
  Hardness  - 3 
  Specific gravity - 7.6 
 The zinc blends structure with 5.82 A the shortest HgS distance in the same  as in 
cinnabar.  Black one is found in nature in small amount. 
 The meta cinnabar is the natural of mercury II sulphide black variety.  But it also 
be synthesized artificially by following methods. 
 Passing hydrogen sulphide (H2S) gas into mercurial salt solution. 
 Hg++ + H2S HgS+2H+ 
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Conversion of mercury II sulphide (black) to mercury sulphide (red) 
1. In black variety is heated up to 500 C.  It changes to red. 
2. When the black powder of mercury II sulphide is sublimated to 446C. 
3. It yields red form of  HgS. 
4. In ancient period it was prepared by vaidya using Hg and S in 5:1 ratio 
5. Cinnabar on heating in a test tube.  It sublimes and fumes of SO4 and black 
mercury sulphide are obtained.  Cinnabar by heating either in a current of air or 
with the addition of iron or quick lime giving or yielding mercury. 
• When treated with an a current air. 
HgS + O2 → Hg +O2 
• When Erected with Iron 
HgS + 2 Fe → Hg + Fe2S 
• With quick lime 
HgS + CaO → Hg +CaS + CaSo4 
  According to report of Dr.Chahergy, Cinnabar contains 86.22% mercury and 
13.78% of sulphur 
 It is black in acid medium while in renstral medium.  Change of red coloured 
cinnabar powder to back in presence of 3 myrobalans of fruit juice is due It change in pH 
value.  Neutral form of mercuric sulphide is obtained by reacting sublimated mercury and 
sulphur in kupi pak vs.apparatus. 
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3.1.3.LATERAL RESEARCH 
Mercury in traditional medicines: Is cinnabar toxicologically similar to common 
mercurials. 
Jie Liu, Jing-Zheng Shi, [...], and Michael P. Waalkes 
Abstract 
Mercury is a major toxic metal ranking top in the Toxic Substances List. Cinnabar 
(contains mercury sulfide) has been used in traditional medicines for thousands years as 
an ingredient in various remedies, and 40 cinnabar-containing traditional medicines are 
still used today. Little is known about toxicology profiles or toxicokinetics of cinnabar 
and cinnabar-containing traditional medicines, and the high mercury content in these 
Chinese medicines raises justifiably escalations of public concern. This minireview 
searched the available database of cinnabar, compared cinnabar with common mercurials, 
such as mercury vapor, inorganic mercury, and organic mercury, and discusses 
differences in their bioavailability, disposition, and toxicity. The analysis showed that 
cinnabar is insoluble and poorly absorbed from the gastrointestinal tract. Absorbed 
mercury from cinnabar is mainly accumulated in kidney, resembling the disposition 
pattern of inorganic mercury. Heating cinnabar results in release of mercury vapor, which 
in turn can produce toxicity similar to inhalation of these vapors. The doses of cinnabar 
required to produce neurotoxicity are thousands 1000 times higher than methyl mercury. 
Following long-term use of cinnabar, renal dysfunction may occur. Dimercaprol and 
succimer are effective chelation therapies for general mercury intoxication including 
cinnabar. Pharmacology studies of cinnabar suggest sedative and hypnotic effects, but the 
therapeutic basis of cinnabar is still not clear. In summary, cinnabar is chemically inert 
with a relatively low toxic potential when taken orally. In risk assessment, cinnabar is less 
toxic than many other forms of mercury, but the rationale for its inclusion in traditional 
Chinese medicines remains to be fully justified. 
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3.2. ACONITUM HETEROPHYLLUM – nkquqmbl<<<<!
3.2.1. GUNAPADAM ASPECT 
Synonyms 
Atthiranam, Pangurai, Mathiri 
Vernacular names 
English: Indian Atis Root 
Tel : Ati-Vasa 
Mal : Athividayam 
Kan : Bhangura, upavishankan  
Sans : Ativisha 
Pers : Vajje-turki 
Hind : Atlis 
Duk : Atvika, vajje-turki 
Part used: Root 
Oraganoleptic character 
Taste (Suvai)  : Bitter (Kaippu), Pungent (Kaarppu) 
Potency (Thanmai) : Hot (Veppam) 
Biotransformation (Pirivu): Pungent (Kaarppu) 
Actions 
 Stomachic (Pasithethoondi) 
 Astringent (Thuvarppi) 
 Febrifuge (Veppagatri) 
 Aphrodisiac (Aanmai perukki) 
 Tonic (Uramakki) 
 Anti periodic (Murai veppagatri) 
General properties 
 nkquq!mbl<si<g<g!vix<HkOfib<!ouh<H!
! ogikqlVU!OhkqobiM!Ogijp!–!wkqi<uif<kq!
! we<Xjvg<Gl<!Ofib<%m<ml<!-z<zi!kgx<xquqMl<! !
Ge<jx!fqgi<Ljzbib<"!%X!
! ! ! .!G{himl<!&zqjg!uGh<H!
Indian atis root is used to treat wounds, fever, diarrhoea, cough, vomitting & 
subsides fever.  It is used as anti-periodic and febrifuge by allopathic doctors. 
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Traditional uses 
 Indian atis root powder 1300mg to 19 grams mixed with honey is given per 
periodic fever. 
 3200 gram to 6500 gram Indian atis Root powder is given thrice a day for 
weakness developed after fever. 
 Dicoction for diarrhoea with fever 
Athividayam, chukku, Kudasapallai pattai, muthakasu, seenthilkodi, each 
1 ¼  varagan add it to uzhaku water dehydrated to 4:1 ratio. 
 
ATHIVIDAYAM IN OTHER MEDICINES 
1. GANTHAGA SINTHAMANI CHOORANAM 
 Indication  : Bedhi 
 Dosage : Verukadi alavu (1250 – 1500mgm) 
2. AANANDHA CHOORANAM 
 Indication :  Bedhi 
 Adjuvant : Honey 
3. PATTAI CHOORANAM 
 Indication :  Bedhi 
 Dosage : Verukadi alavu (1250 – 1500mgm) 
 Adjuvant : Honey (or) Ghee 
4. DHARMAR MATHIRAI 
Indication :  Bedhi 
 Dosage : Thoothulangai alavu   (0.5803gm) 
Adjuvant : Honey 
5. MADHULAIYATHI KULIGAI 
Indication :  Bedhi 
 Dosage : Sundaikkayalavu (0.798gm) 
Adjuvant : Buffalo curd 
6. VIDAIYATHI MATHIRAI 
Indication :  Bedhi 
 Adjuvant : Decoction of cumin seeds 
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ACONITUM HETEROPHYLLUM 
3.2.2. BOTANICAL ASPECT 
Taxonomical classification 
Kingdom :  Plantae 
Division :  Angiosperms 
Class  :  Eudicots 
Order  : Ranunculales 
Family  : Ranuculaceae 
Genus  : Aconitum 
Species : Heterophyllum 
Botanical name :   Aconitum heterophyllum linn 
Habitat 
 Usually found on humus – rich soils in the alpine and subalpine zones and in 
forests 2300-2900 meters. 
Description 
Leaves 
 Heteromorphous, glabrous, lowest on long panicle blade-orbicular-cardate (or) 
ovate-cardate in outline with a usually narow sinus, 5-lobed to middle, amplexicual. 
Flower 
 Inflorescence slender raceme (or) lax, leafy panicle, cripso-pubescent, sepals 
bluish (or) violet, navicular obliquely erect, shortly (or) obscurely beaked 18-20 mm high, 
8-9mm wide, carpels-5, elliptic oblong. 
Root 
 Biennial paired, tuberous, whitish (or) grey. 
Stem 
  Erect, simple (or) branched from 15-20 cm high glabrous below. 
Seeds 
 Pyramidal 3-4mm long, blackish brown. 
Chemical constituents 
Aconitum heterophyllum contains 
 Alkaloids, amide alkaloids, flavonoids, flavonol glycosides, diterpenoid and 
norditerpenoid compounds. 
 Atisine, Heteratisine, heterophyllisine, heterophylline and heterophyllidine. 
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Therapeutic uses 
 The root powder of ativisha with honey is prescribed for cough irritations and 
bronchitis. 
 It is a good bitter remedy against gastroenteric fevers amongst infants and 
children. 
 It is also useful in rheumatism, nervous pains as an analgesic. 
 Inhalation of roots by nose in beneficial in headache, especially migraine. 
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3.2.3. LATERAL RESEARCH 
A REVIEW ARTICLE ON AYURVEDIC/ HERBAL PLANT “ARUNA” (ACONITUM 
HETEROPHYLLUM). in International Journal of Advanced Research Int. J. Adv. 
Res. 5(2(1 FEB):319-325· February 2017 with 404 Reads DOI: 
10.21474/IJAR01/3150 
 
Abstract 
  In modern days there are Allopathic medicines are most widely used for general 
treatments. Herbal medicine are major remedy of Traditional and Ayurvedic medicine 
systems. Herbal or Ayurvedic medicine are less toxic or side effects. Medicinal plants are 
playing an important role in the drug discovery and development of new molecules. There 
are a number of herbs which are used from ancient time Aruna (Aconitum heterophyllum) 
is important herbs because in this medicinal plant there are a lot off pharmacological 
activity like Anti-inflammatory, hepatoprotective , Digestive activity. But some species of 
Aconitum plant is poisons in nature. This review should be of interest to readers in the 
areas of Pharmacognostical and Pharmacological activity and indication of Aconitum 
heterophyllum. And Aconitum Heterophyllum is one of the herbs which are used for its 
medicinal properties. Aconitum species belongs to the family Ranunculaceae . It’s about 
300 species are found in all over the world but in India, only 24 species are found in the 
Himalayas sub-alpine and alpine region, suits required about 2400-3600 m altitude above 
sea level. Seed germination micro propagation method is used for the cultivation of 
Aconitum plants. Aconitum heterophyllum has a lot of pharmacological use like in the 
treatment of urinary infection, diarrhoea, as an expectorant, Anti-inflammatory, 
hepatoprotective activity. It is a good source of diterpene alkaloids, flavonoids. There are 
some indication occurs in Aconitum heterophyllum roots part: Nausea, Bleeding piles, 
Periodic fever, Dyspepsia, Diarrhea, Dryness of mouth. When taken in larger doses may 
cause constipation. 
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3.3. MYRISTICA FRAGRANS –!sikqg<gib<< << << < 
3.3.1.GUNAPADAM ASPECT 
Synonyms 
Kulakkai, Jathikkai 
Vernacular names 
Sanskrit  - Jati – Phalam 
English  - Nutmeg 
Hindu.Duk & Ber - Jayphal, Jaiphal, Jaepatri 
Telungu  - Jejikaya 
Tamil   - Jadikkay, Jathikkai 
Malayalam  - Jathika 
Can   - Jajikai 
Burm   - Zadu-phu 
Malay   - Bush-pala 
Partused : Unriped fruit 
Organoleptic Characters 
Taste (Suvai)   : Astringent (Thuvarppu),   Pungent (Kaarpu) 
Potency (Thanmai)  : Hot (veppam) 
Bio Transformation (pirivu) : Pungent (Kaarpu) 
osb<jg<<< !
 Stimulant (Veppamundakki) 
 Carminative (Agattuvaivagatri) 
 Narcotic (Moorchaiundakki) 
 Aromatic (Manamooti) 
 Aphrodisiac  (Kamam peruki) 
 Tonic (Uramakki) 
General properties 
kiKfm<ml<!Ohkq!sVuisq!bR<sqvOfib<!
YKSui!sr<gisl<!dm<gqv{q!–!OuOki!
czg<gib<!uVl<hq{qOhil<!Wx<xlbz<!hqk<kr<!
Gzg<gi!bVf<Kui<Gg<!%X/!
- G{himl<!&zqjg!uGh<H!
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Nut meg is useful in the cases of oligospermia, diarrhoea, headache, asthma, 
cough, stomachache  bloated abdomen. 
Traditional uses 
 Decoction of nutmeg is used for dehydration in the case of vomitting and 
diarrhoea 
 Nutmeg paste is applied around the eyes to promote eye sight. 
 Nut meg oil is used for tooth ache. 
 Nutmeg powder 130mg, dry ginger powder 130 mg and cumin seed powder 
130mg taken internally before meals for indigestion 
 For diarrhoea 2 grams of nutmeg powder is given with milk. 
SATHIKKAI IN OTHER MEDICINES 
1. SATHIKKAI LEGIUM 
Indication :  Ratha bedhi, Seetha bedhi 
 Dosage : Kalarchikkai alavu (3 gms) 
2. VAJIRAKANDI LEGIUM 
Indication :  Athisara bedhi,  Ratha bedhi 
 Dosage : Sundaikkai alavu (0.798gm) 
3.KIRANI MATHIRAI 
Indication :  Gunmam, Sobai, Kirani 
 Dosage : Uchi karandi  alavu (16ml) 
4. PULIYARAI KIRUTHAM 
Indication :  Gunmam, Sobai, Kirani 
 Dosage : Uchi karandi alavu (16ml) 
5. JATHIBALATHI CHOORANAM  
Indication :  Kirani, Ratha bedhi, Seetha bedhi 
 Dosage : Thirikadi alavu (800 – 1000mgm) 
Adjuvant : Honey 
6. KATTUVAI CHOORANAM 
Indication :  Bedhi 
 Dosage : Thirikadi alavu (800 – 1000mgm) 
Adjuvant : Honey 
7. KABADA MATHIRAI 
Indication :  Bedhi 
 Dosage : Ilanthai vithai alavu (790mgm) 
Adjuvant : Honey 
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MYRISTICA FRAGRANS 
3.3.2. BOTANICAL ASPECT 
Classification 
Taxonomical Classification 
Kingdom  : Plant kingdom 
Division  : Flowering plant 
Class   : Dicotyledonae 
Subclass  : Monopetalae 
Series   : Microembryeae 
Family   : Myristicaceae 
Genus   : Myristica 
Species  : Fragrans 
Habitat 
 Nutmeg tree is indigenous to the Malay, Peninsula, Moluccas and Penang, now 
cultivated in many tropical countries of both hemispheres.  In India, it is grown in Madras 
state (Nilgiris, Coimbatore, Salem, Ramanathapuram, Tirunelveli, Kanyakumari and 
Madurai Districts) a few trees are found invarious localities in kerala, Assam and other 
states.  Preliminary trials have shown that Araku Valley (Andrapradesh), wynaad 
(Madrasstate) are well suited for its cultivation. 
Description 
Habit: 
 Moderate sized usually dioecious evergreen aromatic tree, upto 12mm tall. 
Leaves 
 Alternate, quite entire exstipulate, often pellucid-punctate. 
Flowers 
 Dioecious, small, regular fascicled umbelled or panicled.  Bracteoles persistent or 
caducoas. 
Male Flowers 
 Perianth-3 (2-4) lobed, valvate in bud.  Anthers 3 or more connate in a sessile or 
stropitate column head ring or disk, 2-celled. 
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Female flowers: 
 Perianth of the male, staminodes 0. ovary superior, free sessile, 1-celled style 
short or a stigma capitate, discoid or lobed, ovale, basal, erect, anatropous. 
Fruit 
 Fleshy at length 2 rarely 4 – Valved. 
Seed 
 Erect, enclosed in a thin or fleshy entire or lacerate often highly coloured aril, 
testa thin or crustaceous, albumen hard densely ruminate, embroyo basal, small, 
cotyledons rounded spreading often wrinkled, radicle short inferior. 
Macroscopic Description of seed 
 Seed ellipsoid, 20-30 mm long and about 20mm broad, externally greenish brown 
sometimes marked with small irregular, dark brown patches or minute dark points and 
line slightly focused reticulately, a small light coloured area at one end indicating the 
position of the radicle.  A grove running along the line of raphe to the darker chalza at the 
opposite end, surrounded by a thin layer of perisperm with infoldings appearing as dark 
ruminations in the abundant greyish brown endosperm, embryo in an irregular cavtiy, 
small with two widely spreading crumpled colyledons and a small redicle, odour, strong 
and aromatic, taste, pungent and aromatic. 
Microscopic Description of seed 
 Transverse section of endosperm show peripheral perisperm, of several layers of 
strongly flattened polyhedral cells with brown contents or containing prismatic crystals, 
inner layer of perisperm of thin walled parenchyma about 40 µ thick, infolding into the 
tissue of the endosperm to form the raninations containing numerous very large oil cells 
with brown cell walls, vascular strands, in the peripheral, region numerous small spiral 
vessels, large called, endosperm parenchymatous with occasional tannin idioblasts, with 
the brown walls, containing numerous simple rounded and compound starch grains, with 
upto about 10 componenets usually 2-8, individual grains, upto 2 µ in diameter present 
most of the cells with crystalline fat and often a large aleurone grain in each cell, 
containing a rhombic protein crystal upto 12 µ and small aleurone grains with less regular 
crystalloids, embryo of shrivelled and collapsed parenchyma. 
Chemical constituents 
The main chemical compounds are 
 a-pinene, camphene, b-pinene 
 Sabinene, myrcene, a-phellandrene 
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 a-terpinene, limonene, 1, 8 cinede, y-terpinene, linalool, terpinen-4-ol 
 Safrole, methyl legend and myristicin. 
Therapeutic uses 
 Oil of nutmeg is employed for flavouring food products and liquorus 
 It is used for scenting, soaps, tobacco and dental cream. 
 It has been recommended for treatment of inflammation of bladder and urinary 
tract. 
 Alcoholic extract of nutmeg shows anti-bacterial activity against micrococcus 
pyogenes, aqueous decoctions are toxic to cockroaches. 
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3.3.3.LATERAL RESEARCH: 
 ANTI-INFLAMMATORY ACTIVITY OF MYRISTICA FRAGRANS (NUTMEG) 
USING HRBC MEMBRANE STABILISING METHOD INT. J. PHARM. SCI. REV. 
RES., 44(1), MAY - JUNE 2017; ARTICLE NO. 11, PAGES: 40-42 
 
ABSTRACT : The aim of the study is to determine the anti-inflammatory activity of 
Myristica fragrans (Nutmeg) using HRBC membrane stabilising method. Inflammation 
being a common symptom for various diseases has to be treated properly. The anti-
inflammatory drugs come into role here in decreasing the inflammation. Nutmeg spice is 
a good source of minerals like copper, potassium, calcium, manganese, iron, zinc and 
magnesium. Since it's a natural drug and has a lot of anti-inflammatory properties having 
no side effects, therefore it is better than synthetic drugs. Nutmeg being a natural drug 
with least side effects, in comparison with the other drugs can be used in the future to 
produce an efficient anti-inflammatory drug. 
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3.4.  MYRSTICA  FRAGRANS, GRONOV  - sikqhk<kqiq<<<  
3.4.1.  GUNAPADAM ASPECT: 
Synonyms: 
Vasuvaasi, Jathipathiri. 
Vernacular names: 
Eng – Arillus of the nut. 
Tel – Japtri. 
Mal – Jatipatri. 
Kan – japtri. 
Sans – Jatipattriri. 
Arab – Bisbasah. 
Pers – Bazbaz. 
Hind – Javatri. 
Puk – Joutri. 
Parts used:  
             Arillus of the nut. 
Organaoleptic Charactes: 
  Taste (Suvai)        -    pungent (Kaarpu). 
           Potency  (Thanmai)   -   hot (Veppam) 
  Bio-transformation   -   pungent (Kaarpu). 
Actions: 
           Aphrodisiac (Kamamperukki) 
           Carminative (Agattuvaivagatri) 
           Stimulant (Veppamundakki) 
           Hypnotic. (Urakkamundakki) 
General Properties: 
!!!!!sikq!kVl<!hk<kqvqg<Gk<!kihs<!Svf<k{qBl<!
!!!!!YKgqe<x!hqk<kl<!dbVr<gie<!.!kiKuqv<k<kq!
!!!!!B{<mir<!gqvg{qObi!Omikg<!gpqs<szXl<!
! h{<mir<!GjxOb!hgi</!
- G{himl<!&zqjg!uGh<H!
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              Sathipathiri cures thabasuram, dysentery, diarrhea. It also strengthen the body. It 
induces the azhal. 
Therapeutic Uses: 
              Oil extract checks gastric trouble and diarrhoea. 
              This increases the semen secretion. 
               Fever, tuberculosis, chronic stomach ache are treated by sathipathiri. 
               It gives strength to uterus. When this powder is inhaled, it relieves headache and 
epileptic fits. 
               This is also used in low stages of fever, chronic diarrhoea, asthma and chronic 
bowel complaints. 
 
SATHIPATHIRI IN OTHER MEDICINES 
1. KATTUVAI MATHIRAI 
Indication :  Bedhi 
 Adjuvant : Mother’s milk 
     -  Anuboga Vaidhiya Brahma Ragasiyam 
2. BAIRAVA MATHIRAI 
Indication :  Gunmam, bedhi. 
 Dosage : Kundri alavu (130mg) 
     -  Anuboga Vaidhiya Brahma Ragasiyam 
3. IMPOORAL ILAGAM 
Indication :  Kuruthi kazhichal 
 Dosage : 1-2 gm 
     -  Koshayi Anuboga Vaidhiya brahma Ragasiyam  
4. KESARI ILAGAM 
Indication :  Kuruthi kazhichal 
 Dosage : 2-4 gm 
5. KADUKKAI ILAGAM 
Indication :  Athisaram, Kirani 
 Dosage : Punnaikkayalavu (3-5 gms) 
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MYRSTICA FRAGRANS!
3.4.2.   BOTANICAL ASPECT:  
Taxonomical classification: 
           According to Bentham and Hooker’s classification, Myrstica fragrans is classified 
as follows: 
           Kingdom    :    Plant kingdom 
           Division     :    Flowering plant 
   Class          :     Dicotyledonae 
          Sub-class    :    Monopetalae 
          Series      :     Microembryeae 
          Family    :     Myristicaceae 
         Genus      :    Myristica  
         Species   :    fragrans 
Distribution: 
          Nutmeg tree is indigenous to the Malay, Peninsula, Moluccas and Penang, now 
cultivated in many tropical countries of both hemispheres. In India it is grown in Madras, 
Nilgiris, Coimbatore, Salem, Ramanathapuram, Tirunelveli, Kanyakumari and Madurai 
district. A few trees are found in various localities in Kerala, Assam and other states. 
Preliminary trials have shown that araku valley (Andhra Pradesh), waynnad (Madras 
state) are well suited for cultivation 
Description: 
            Mace , spice consisting of the dried aril, or lacy covering, of the nutmeg fruit of  
Myristica fragrans, a tropical evergreen tree. Mace has a slightly warm taste and a 
fragrance similar to that of nutmeg. In the processing of mace, the crimson-coloured aril 
is removed from the nutmeg that it envelops and is flattened out and dried for 10- 14 
days; its colour changes to pale yellow, orange or tan. Whole dry mace consists of flat 
pieces-branched or segmented, smooth, horny and brittle-about 40mm (1.6 inches) long. 
Chemical constituents: 
  Mace and mace oil have the same constituents as nutmeg and nutmeg oil but with 
a higher concentration of myristicin and less amount of fixed oil. 
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3.4.3.  LATERAL RESEARCH: 
Pharmacognostic, phytochemical, physicochemical and TLC profile study Mace 
(Aril) of Myristica malabarica 
 Lamk. (Myristicaceae) Seema Yuvraj Mendhekar*, Chetana Dilip Balsaraf, 
Mayuri Sharad Bangar, S.L. Jadhav, D.D. Gaikwad  
 
ABSTRACT  
             The plant Myristica malabarica Lamk. is traditionally used as a medicine and 
spices in food . It is belonging to family Myristicaceae. The plant is native to India and 
endangered trees are mostly found in western ghat. Extracted with various solvents by 
successive soxhlet hot extraction processs with increasing order of polarity on 
phytochemical investigation. The extract has shown alkaloids, saponin, tannin and 
flavones glycosides. It has important medicinal uses like Ayurvedic Medicines. It is 
traditionally used as anticancer, antiInflammatory, anti-Oxidant, Sedative hypnotics, 
Antimicrobial, Antifertility, Hepatoprotective and cytotoxicity. The chemical constituents 
such as Malabaricones, Malabaricanol, Isoflavones are isolated .Myristica Fragrans also 
known as fragnant Nutmeg or true Nutmeg. The present study i.e. Pharmacognostic, 
Phytochemical, Physicochemical and TLC Profile Study of Mace (Aril) Of Myristica 
malabarica Lamk. is helpful in the characterization of the crude drug. Physiochemical and 
phyto-chemical analysis of mace confirm the quality and purity of plant and its 
identification. The information collected is useful for further pharmacological and 
therapeutical evaluation of mace (Aril) Of Myristica malabarica Lamk. and anthology of 
quality control of crude drug. Keywords: Myristica fragrans, Malabaricone, 
Malabaricanol, Phytochemical screening, Microscopical study, TLC 
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3.5. BOMBAX MALABARICUM, DC. - -zul<hqsqe<< << << <!
3.5.1. GUNAPADAM ASPECT 
Synonyms: 
 Mul ilavam, Sanmali, poorani, pongar, mosam. 
Vernacular names 
Tamil : (Mul) Elavu 
English: Red silk-cotton tree 
Hindi : Ragai-senbal 
Tel : Mundla-buraga chettu 
Mal : Mul-elava 
Kan : Mullu-buraga Mara 
Duk : Kantno-ka-sema 
Sans : Kantaka-shalmali 
Part used 
 Leaf, flower, seed, Bark, gum, root 
Organoleptic characters 
Taste (Suvai)  : Sweet, Astringent (Inippu, Thuvarppu) 
Potency(Thanmai) : Coolant (Inippu) 
Biotransformation (Pirivu) : Sweet (Inippu) 
Actions 
 Refrigerant (Kulirchiyundakki) 
 Styptic (Kuruthi perukkadaki) 
 Astringent (Thuvarppi) 
 Tonic (Ullalalaatri) 
 Diuretic (Siruneer peruki) 
General properties 
 “kf<KOl!gR<sqXfQIk<!kijvouh<!hl<uiB!
! Uf<kuV!Ohkqbqju!Obim<Mr<gi{<!!.!Lf<kqg<!!
! gqti<ut<jt!hiBl<uiqg<!og{<jm!uqpqbib<"!
! uti<Lt<!tqzU!lvl</” 
    - G{himl<!&zqjg!uGh<H!
!
!
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Traditional uses 
 The leaf paste of red silk cotton tree is given with milk for burning micturation. 
 Decoction prepared from flower of Red silk cotton tree releives constipation and 
anuria. 
 Decoction prepared from bark of red silk cotton tree given internally, thrice a day 
cures chronic wounds, burning micturation, oliguria, anuria, leucorrhoea and 
diarrhoea. 
 1-2 gram gum powder of Red silk cotton tree with tender coconut for leucorrhoea 
& diarrhoea. 
 
ELAVAMPISIN IN OTHER MEDICINES 
 
1.INJI NEI 
Indication : Diarrhoea   
- (Agathiyar 2000-3rd part, P.No.308) 
2. VETPALAI NEI 
Dosage : 1 teaspoon 
Indication :  Diarrhoea 
- (Agathiyar 2000-3rd part, P.No.306) 
3.VILVATHI CHOORANAM 
Dosage : Mooviral alavu (800mg – 1000mg) 
Adjuvant : Honey 
Indication : Diarrhoea 
- (Agathiyar 2000-3rd part, P.No.165) 
4.THURBATHI VADAGAM 
Dosage : Kottaipakku alavu (6 gms) 
Adjuvant : Honey (or) curd 
Indication : Diarrhoea, dysentry  
- (Agathiyar 2000-3rd part, P.No.198) 
5. NARATTHAMPAZHA NEI 
Indications : Diarrhoea 
- (Agathiyar 2000-3rd part, P.No.304) 
6. ASAMODHATHI CHOORANAM 
Dosage : Mooviral alavu (800mg-1000mg) 
Adjuvant : Hot water 
Indication : Diarrhoea 
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BOMBAX MALABARICUM 
3.5.2. BOTANICAL ASPECT 
Taxonomical classification 
Kingdom : Plant 
Division : Tracheophyta 
Subdivision : Spermatophytina 
Class  : Magnoliopsida 
Order  : Malvales 
Family  : Malvaceae 
Genus  : Bombax 
Species : Bombax malabaricum, DC. 
Habitat 
 Thrives hot, moist, tropical forest, with high rainfall well distributed throughout 
year, such as in the hotter regions of india, estern himalayas and bengal. 
Description 
Habit 
 Deciduous large tree up to 20-25m tall and spreads 8-15m wide. 
Macroscopic character 
 The pieces of bark of bombax is generally curved fragments, 0.5-1cm thick, 
freshly collected bark is brownish internally and externally light grey in colour.  Bark is 
covered with hard, sharp, conical prickles. 
Leaves 
 Palmate with about 6 leaflets, radiating from a central point, 7-10cm wide, 13-
15cm in length.  The leaf’s long flexible petiole is up to 20cm long. 
Stem 
 Woody, solid, erect, grey, glabrous bark prickles, delicate branches cylindrical, 
smooth with distinct nodes. 
Flower 
 Cup-shaped flowers solitary or clustered, axillary or sub-terminal stigma is light 
red, upto 9cm in length. 
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Fruit 
 Brown oval capsule, which, when rip contains white fibers like cotton. 
Gum 
 Gum is light brown in colour resembling the galls and gradually becomes opaque 
a dark brown. 
Chemical constituents: Phytochemicals 
Bombax malabaricum contains,  
• Taraxeryl acetate 
• Squalene 
• Taraxerol 
• Taraxerone,  
• β-sitosterol palmitate 
• 1 H-indole-3-carboxylic acid 
• Lolilide. 
Lupeol isolated from extract of the stem bark. 
Therapeutic uses 
 Decoction of the bark is given orally for fever. 
 Decoction of the heartwood treat diabetes 
 Bark juice is given to reduce stomachache. 
 Cream is prepared from Bombax along with other plants to treat pimples and skin 
eruptions. 
 Root powder of Bombax  malabaricum has been used for heart disease and 
diabetes. 
 Young roots are astringent, stimulant. 
 Stem bark extraction with curd is given for bloody dysentry. 
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3.5.3. LATERAL RESEARCH: 
  Asian Journal of Pharmaceutical Education and Research Vol -6, Issue-3, July-
September 2017 ISSN : 2278 7496 AJPER July-September 2017, Vol 6, Issue 3 (16-27)   
Pharmacognostic and Pharmacological Profile of Bombax Ceiba  
Abstract  
  Bombax ceiba Linn. is a tall tree buttressed at the base that is widely distributed 
throughout India, Ceylon and Malaya, upto 1500 m of altitude. Bombax ceiba is 
commonly known as silk cotton tree and semal which belongs to family Bombacaceae. Its 
medicinal usage has been reported in the traditional systems of medicine such as 
Ayurveda, Siddha and Unani. It has wide range of medicinal and pharmacological 
application. Many parts of the plant (root, stem bark, gum, leaf, prickles, flower, fruit, 
seed and heartwood) are used by various tribal communities and forest dwellers for the 
treatment of a variety of ailments. The plant literature survey shows the plant possesses 
astringent, cooling, stimulant, diuretic, aphrodisiac, demulcent, and tonic effects and also 
helps in dysentery. It also possesses important pharmacological activity such as 
aphrodisiac, anti-inflammatory and hepatoprotective activity in addition to anticancer and 
anti-HIV activity, anti-Helicobacter pylori, antiangiogenic, analgesic and antioxidant 
activity and hypotensive, hypoglycemic and antimicrobial activity. It is reported to 
contain important phytoconstituents such as naphthol, naphthoquinones, polysaccharides, 
anthocyanins, shamimin and lupeol. This paper provides an overview on 
pharmacological, phytochemical properties and therapeutic benefits of the plant.  
 
  
  
   32 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
3.6.  SYZYGIUM AROMATICUM, LINN  -!-zur<gl<< << << <!
3.6.1.  GUNAPADAM ASPECT: 
Synonyms: 
         Anjugam, urkadam, karuvai kirambu, sosam, thirali, varangam. 
Vernacular names: 
  Eng   :  cloves 
Tel   : lavangalu, lavanga poo 
Mal   :  karambu 
Kan   :  lavanga 
 Sans  :  long  
Arab   :  lavangam 
Pers   :  aaranful 
Hind   :  long 
Tamil   :  kirambu. 
Parts used: 
      Flowering bud. 
Organaoleptic Charactes: 
  Taste   (Suvai)    :  pungent (Kaarpu) 
             Potency (Thanmai)  :  hot (Veppam) 
Actions: 
 Anti-spasmodic (Isivagattri) 
 Carminative (Agattuvaivagatri) 
 Stomachic (Pasitheethoondi) 
General Properties: 
            hqk<k!lbg<gl<!OhkqObiM!uif<kqBl<Ohil<!
!!!!!Sk<kuqvk<!kg<ggMh<Hf<!Okie<XOli!–!olk<k!
!!!!!-zur<gr<!ogi{<muVg<!Ogx<!SgliGl<!
!!!!!Lzlr<Og!gm<MOle!uip<k<K/!
!!!!!Sg<gqzfm<!mr<gi<{!S,v<uqbr<g!ziR<sef<kim<!
!!!!!sqg<gqz<uqmis<!si<ui!sqbh<hq{qB!–!lg<gqg<Gm<!
!!!!!mr<gh<!H,OuiM!kiqhmVf<<!Okie<xqzqz<!
!!!!!ur<gh<H,!OuiMjvk<K!ui/!
. Gunapadam Mooligai Vaguppu 
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  Kirambu cures giddiness, diarrhoea, vomiting, dysentery, chronic diarrhoea, ear 
diseases, red mole and black mole. 
Therapeutic Uses; 
          Medicinally they are used as to correct gripping caused by purgatives. 
          It is also used to relieve the presence of excessive gas in the digestive tract, various 
forms of gastric irritability, colic dyspepsia and increase the flow of saliva. 
          Lavangathi chooranam made of cloves, dry ginger, black pepper and  fried borax 
taken equal measure is useful in bronchitis. 
          It is an appetizer and also stops vomiting. 
 
KIRAMBU IN OTHER MEDICINES 
1. OOZHI MATHIRAI 
Indication :  Athisaram, Kirani 
 Dosage : Kundri alavu (130mg) 
2. KABADA MATHIRAI 
Indication :  Bedhi 
 Dosage : Ilanthai vithai alavu (790mg) 
Adjuvant : Honey 
3. GANTHGA RASAYANAM 
Indication :  Bedhi, Moolam, Gunmam. 
 Dosage : 10 to 15 kundrimani alavu  
4. KARISALAI LEGIUM 
Indication :  Bedhi 
 Dosage : Punnaikkayalavu(3-5gms) 
5. INJI VADAGAM 
Indication :  Bedhi, Seriyamai 
 Adjuvant : Water 
6. POORA MATHIRAI 
Indication :  Bedhi 
 Adjuvant : Honey (or) Mother’s, milk 
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SYZYGIUM AROMATICUM 
3.6.2.   BOTANICAL ASPECT:  
Taxonomical classification: 
Kingdom  :  Plantae 
Division  : Magnoliophyta (flowering plants) 
Class   :  Magnoliopsida (dicotyledons) 
Subclass  :  Rosidae 
Order   :  Myrtales 
Family  :  Myrtaceae 
Genus   :  Syzygium 
Species  :  S. aromaticum 
 
Distribution: 
         Indonesia, Tanzania, Madagascar, Malaysia, Brazil, Srilanka, Huait and India are 
the major clove growing countries. The islands of Zanzibar and Pemba are the world’s 
largest producer of  clove, which supplies 90 percent of the total demand followed by 
Indonesia. 
Description: 
       Flowers occur in terminal clusters. Unopened flower buds are green first, then slowly 
change to pink or red or crimson, then finally bright red when is full blown. Each flower 
is about 6mm wide. Flowering occurs when the tree reaches 5-7 years. Cloves are 
harvested at 1.5-2 cm long, and consist of a long calyx that terminates in four spreading 
sepals, and four unopened petals that form a small central ball. 
Chemical constituents: 
      Eugenol composes 72-90% of the essential oil extracted from cloves and is the 
compound most responsible for clove aroma. Other important essential oil constituents of 
clove oil induce acetyl eugenol, beta-caryophyllene and vanillin, crategolic acid, tannins 
such as bisornin, gallotannic acid, methyl salicylate, the flavanoids eugenin, kaempferol, 
rhamnetin and eugenitin, triterpenoids such as oleanolic acid, stigmasterol and 
campesterol and several sesquiterpenes.  
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3.6.3.  LATERAL RESEARCH: 
 
 In vitro controlling of selected human diarrhea causing bacteria by clove extracts 
(Syzygium aromaticum L.)  ISSN: 2221-1063 (Print) 2222-503X 
 
 Abstract  
  Antibacterial activity of clove extracts (Syzygium aromaticum L.) was proven 
against five diarrhea causing bacteria. This was further confirmed when compared with 
commonly used three commercial antibiotics (ciprofloxacin, tetracycline and 
erythromycin) as a positive control. Significant differences (P<0.0001) were observed in 
the effect of the antimicrobial agents (clove extracts and antibiotics), and in the 
sensitivities of the bacterial species (P<0.0001) to the antimicrobial agents. Clove extracts 
had significant (P<0.001) activity with the acetone extract demonstrating highest activity 
followed by antibiotics and other extracts against tested bacteria. The zone of inhibition 
of clove extracts was ranged from 7.33 to 12.00 mm whereas in antibiotics, it was 0.00 to 
11.67 mm. Of all the bacteria, Salmonella typhimurium was the most susceptible against 
all of the extracts as well as concentrations of clove, while low MIC (180 mgml-1) and 
MBC (680 mgml-1) of the extracts were observed against Shigella dysenteriae. 
Consequently, clove has a significant antidiarrheal activity and it could be used as an 
effective antibacterial agent, alternative to the use of antibiotics. 
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3.7.ACACIA CATECHU (Lin.f)wild – gib<s<Sg<gm<c< < < << < < << < < < !
3.7.1.GUNAPADAM ASPECT 
Vernacular names 
Tamil  :  Karungali 
English :  Black catechu, Cutch tree 
Tel  :  Chandra 
Mal  :  Karingali 
Kan  :  Khadira 
Sans  :  Khandira 
Hind  :  Katha 
Duk  :  Kher 
Part used 
 Bark, Gum, Root. 
Organoleptic characters 
 Taste (suvai)   : Astringent (Thuvarppu) 
 Potency (Thanmai)  : Coolant (Inippu) 
 Biotransformation (pirivu)  : Pungent (Kaarpu) 
Actions 
 Astringent (Thuvarppi) 
General properties 
 Gm<mr<!gbOvigr<!Ge<ll<!ohVubqX!
! ofm<jmh<!HPkqlqV!fQiqpqUl<!.!uqm<Om!
! bVr<gie!gk<OkG!lR<SgOl"!fz<z!
! gVr<gizqh<!fQvkjeg<!g{<M/!
!! ! ! .!G{himl<!&zqjg!uGh<H!
Black catechu is used to treat diseases of leprosy, ascitis, diabetes and anaemia. 
Traditional uses 
 Acacia catechu bark decoction is used to treat diabetes. 
 For fistula, the bark dicoction is given with buffalo ghee and embelia powder. 
 A bark of Acacia catechu, Azadiracta indica and Eugenia jumbolana are made into 
paste with the help of cow’s urine are used to heal wounds. 
 Because of its astringent taste it used to treat diarrhoea and bleeding gums. 
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KAICHUKKATTI  IN OTHER MEDICINES 
1. ARITHAGI CHOORANAM 
Dosage : Verukadi alavu (1250-1500mg) 
Adjuvant : Honey 
Indication : Diarrhoea 
2. KAICHUKKATTI CHOORANAM 
Dosage : Diarrhoea 
Adjuvant : 500mg -  1 gm 
Indication : Ghee 
3. KIRANI KABADAM 
Dosage : Diarrhoea 
Adjuvant : Ilanthai vithai alavu (790mg) 
Indication :  Curd 
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ACACIA CATECHU 
3.7.2. BOTANICAL ASPECT 
Taxonomical classification 
Kingdom  : Plant 
Division  : Tracheophyta 
Class   : Magnoliopsida 
Order   : Fabales 
Genus   : Acacia 
Species  : Acacia catechu (L.f) wild 
Family   :  Fabaceae 
Botanical  name :  Acacia catechu (L.f) wild  
Habitat 
 It grows throughout India from the Himalayas to the south of India. 
Description 
Habit 
 Is a deciduous, thorny tree which grows upto 15m in height. 
Leaf 
 Leaves bipinnate, altermate, stipulate, stipular spines slightly infra axillary, paired, 
3-10mm long, straight or hooked. 
Flowers 
 Flowers pale yellow, sessile, in long solitary or in groups of 2-4 axillary spikes, 
bracts cauducous. 
Fruit 
 A pod 5-10 x 1-1.6 cm, flat, straight, unlobed or sinuate along margins, thin 
walled, beaked at apex. 
Macroscopic characters 
 Black or dark brown in colour, irregular masses or cubes, rough, dull or slightly 
glossy and porous. 
Microscopic characters 
 Bark shows numerous uni to bi-seriate medullary rays, vessels occuring isolated 
or in small groups of two to four.  Xylem fibers with narrow lumen occupying major 
portion of wood. 
  
  
   39 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
Chemical constituents 
 It contains tannins like catechins, catechu tannic acid. 
 Flavonoids like quercetin and it derivatives. 
 Catechu red, gum 
 Catechin 
 Epicatechin 
 Kaempferol 
 Mesquitol, ophioglonin, aromadendrin 4-hydroxybenzoic acid. 
Therapeutic uses 
 It is a valuable astringent given in doses of 5-15 gms, in diarrhoeas and 
haemorrhages. 
 A small piece of catechu with cinnamom held in tooth ache, bleeding, ulcerations 
and sponginess of the gums. 
 It is useful for strengthening gums. 
 Gum is an astringent, demulcent and haemostatic. 
 Gum is useful in diarrhoea, dysentry, menorrhagia and other affections.  
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3.7.3. LATERAL RESEARCH 
PHYTOPHARMACOLOGY OF ACACIA CATECHU WILLD: A REVIEW ejpmr, 
2019,6(1), 216-223 
ABSTRACT 
Khadir (Acacia catechu Willd) beloning to Family-Fabaceae and subfamily-Mimosoideae 
has a great importance due to its medicinal properties and is commonly known as Katha. 
It is a historical plant; widely used in traditional medicine especially in Asia. In charka 
Samhita, vimansthan chapter 8 Khadira (Acacia catechu Willd) included in kashay 
skandha. Kashay rasa plays an important role in kledashoshan (Absorbing Kleda). 
Dhatushaithilyanashan (destroys Dhatushaithilyanashan) beside this kashay rasa has 
vranropan (wound healing) property. Khadir (Acacia catechu Willd) possess 
predominant kashay rasa, sheet veerya and katu vipak. The useful part of Khadira is bark. 
The main chemical constituents of Black catechu are flavanoids (catechin, (-) epicatechin, 
epigallocatechin, epicatechin gallate, epigallocatechin gallate, rocatechin, phloroglucinol, 
procatechuic acid, catecutannic acid, quercetin, quercitrin), alkaloids (kaempferol, 
dihydrokaempferol, taxifolin, afzelchin gum), glycosides (poriferasterol, poriferasterol 
acylglucosides), tannins (gallic acid, phlobatannins), sugars (d-galactose, d-rhamnose and 
larabinose). It has been shown to possess multifarious medicinal properties such anti-
bacterial, anticancer, antidiarrhoeal, anti-inflammatory, antimicrobial, antioxidant, 
antipyretic, anti-ulcer, antisecretory, hepatoprotective, hypoglycaemic, sore throat and 
wound healing and anti-obesity etc.  
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3.8. AEGLE MARMOLOS.LINN –!uqz<ul<< << << <!
3.8.1. GUNAPADAM ASPECT 
Synonyms 
 Kusabi, Koovilam, Koovilai, Sivatthurumam, Ninmali, Maathuram. 
Vernacular names 
Tamil  :  Vilvam 
English :  Bael (tree) Holy fruit tree 
Sans  :  Bilva 
Hindi  : Bel 
Tel  :  Bilvamu 
Mal  :  Kuvalam 
Kan  :  Beta 
Pers  :  Shul 
Part used 
 Leaf, flower, unripe fruit, Root,  Bark. 
Organoleptic characters: 
 Taste (suvai)  : Astringent (Thuvarpu), slightly Bitter (siru kaipu) 
 Potency (Thanmai) : Coolant (Inippu) 
 Biotransformation : Pungent (Kaarpu) 
Actions 
 Diaphoretic (Viyarvai perukki) 
 Aphrodisiac (Kamam perukki) 
 Febrifuge (Veppagattri) 
 Astringent (Thuvarppi) 
 Laxative (Malamilakki) 
 Stomachic (Pasithethoondi) 
General Properties 
 hz<zul<H,!hqR<sqe<!hpfqiqbl<sl<!LjxOb!
! uz<uul<!Olglf<k!liGe<ll<!.!osz<Zgqe<x!
! Ofig<glVt<!uqf<Kfm<m!F~X!lMk<kui<gm<!
! gig<glVt<!uqz<Zuk<kq!zil</!
!! ! ! ! .!G{himl<!&zqjg!uGh<H!
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 Young leaves of vilvam are used to treat secondary syphilis, flower – used to treat 
indigestion, unriped fruit- used to treat gastric ulcer. Fruit – used to treat eye 
diseases.  Resin – used to treat oligospermia.!
 2-6 gram of unriped fruit of vilvam paste mixed with buffalo curd is used to treat 
gastric ulcer, diarrhoea.!
 Manappagu prepared with the help of vilvam fruit is used to treat diarrhoea.!
 2-4mg powder of dried fruit flesh is used to treat diarrhoea.!
 Leaf juice of vilvam with piper nigrum powder used to treat jaundice and dropsy.!
 
VILAVA PAZHAM IN OTHER MEDICINES 
1. THADI MATHI CHOORANAM 
Dosage : 3 viral alavu (800-1000mg) 
Adjuvant : Honey (or) curd  
Indication : Kirani   
- Agathiyar – 2000 – 3rd part. 
2. KORAIKIZHANGU NEI 
Dosage  : 1 Kasu edai alavu (800mg) 
Indication : Diarrhoea, Fever 
- Agathiyar – 2000 – 3rd part 
3. KIRANI KABAPAM 
Dosage : Elanthai alavu (790mg) 
Adjuvant : Curd 
Indication : Kirani  
- Thanjai Vaidhiya raja sinthamani  
4. MADHULAI CHOORANAM 
Dosage : Verukadi alavu (1250-1500mg) 
Adjuvant : Gingelly oil 
Indication : Diarrhoea, indigestion. 
- Anupoga Vaidhiya Murai  
5. MATHA KAJA KANDEERAVAM 
Dosage : Milagu alavu (56mg) 
Indication : Diarrhoea 
- Siddha vaidhiya thirattu  
- Aegle Marmelos 
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AEGLE MARMELOS 
3.8.2. BOTANICAL ASPECT 
Taxonomical classification 
Kingdom :  Plantae 
Sub kingdom :  Tracheobionta 
Division :  Magnoliaphyta 
Class  :  Magnoliopsida 
Sub class :  Rosidae 
Order  :  Sapindales 
Family  :  Rutaceae 
Genus  :  Aegle 
Species :  Marmelos 
Habitat 
 Aegle marmelos is a deciduous shrub or small to medium sized tree, upto 13m tall 
with slender drooping branches and rather shappy crown.  Is native across the indian 
subconfinent and southeast asia and is cultivated throughout srilanka. 
Description 
Macroscopic characters 
  Leaves : Are alternate, pale green, trifoliate, terminal leaflet. 15.7cm long, 2.8cm 
broad, having a long petiole. 
Flowers 
 Greenish white, sweetly scented, bisexual, actinomorphic, stalk 8mm long 
Fruit 
 Yellowish green, with small dots on the outer surface, oblong to globose, 5.3cm to 
7.2cm in diameter weight 77.2gm; yellow & mucilaginous. 
Microscopic characters 
 Presence of characteristic stone cells, compact parenchyma cells and oil globules 
phloem cells were characteristically dark pinkish colour, radially flattened cork cells.  
Presence of brownish granules, laticiferous ducts were unique. 
Chemical constituents: Phytochemicals 
Bael tree contains, 
- Furocoumarins,  
- Xanthotoxol 
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- Flavonoids 
- Rutin and marmesin 
-    Aegeline is a constituent that can be extracted from bael leaves. 
- Agelin, marmeline, aegelenine present 
- Aegle marmelosine. 
- Methyl ester of alloimperatorin 
- A number of essential oil 
- a fargarine 
- O-methylhafordinol 
- Luvangetin, aurapten, Marmelide and tannin 
Therapeutic uses 
- Bael fruits are used in the treatment of chronic diarrhoea, dysentry and peptic 
ulcers. 
- It is gastroprotective, anti-ulcerative. 
- Dry powder of this fruit with mustard oil for the treatment of burns. 
- Fruits are also used in gastric troubles, tonic, digestive, cardiac tonic, antiviral, 
gonorrhea,  epilepsy. 
- The ripe fruit is helpful in treating inflammation of rectum. 
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3.8.3. LATERAL RESEARCH: 
Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit:Validating its 
traditional usage 
 
Abstract 
Background: Aegle marmelos (L.) Correa has been widely used in indigenous systems of 
Indian medicine due to its various medicinal properties. However, despite its traditional 
usage as an antidiarrhoeal there is limited information regarding its mode of action in 
infectious forms of diarrhoea. Hence, we evaluated the hot aqueous extract (decoction) of 
dried unripe fruit pulp of A. marmelos for its antimicrobial activity and effect on various 
aspects of pathogenicity of infectious diarrhoea. Methods: The decoction was assessed 
for its antibacterial, antigiardial and antirotaviral activities. The effect of the decoction on 
adherence of enteropathogenic Escherichia coli and invasion of enteroinvasive E. coli and 
Shigella flexneri to HEp-2 cells were assessed as a measure of its effect on colonization. 
The effect of the decoction on production of E. coli heat labile toxin (LT) and cholera 
toxin (CT) and their binding to ganglioside monosialic acid receptor (GM1) were 
assessed by GM1- enzyme linked immuno sorbent assay whereas its effect on production 
and action of E. coli heat stable toxin (ST) was assessed by suckling mouse assay. 
Results: The decoction showed cidal activity against Giardia and rotavirus whereas 
viability of none of the six bacterial strains tested was affected. It significantly reduced 
bacterial adherence to and invasion of HEp-2 cells. The extract also affected production 
of CT and binding of both LT and CT to GM1. However, it had no effect on ST. 
Conclusion: The decoction of the unripe fruit pulp of A. marmelos, despite having 
limited antimicrobial activity, affected the bacterial colonization to gut epithelium and 
production and action of certain enterotoxins. These observations suggest the varied 
possible modes of action of A. marmelos in infectious forms of diarrhoea thereby 
validating its mention in the ancient Indian texts and continued use by local communities 
for the treatment of diarrhoeal diseases. 
  
  
   46 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
3.9. DATURA METEL – Dlk<jk<<< !
3.9.1. GUNAPADAM ASPECT 
Synonyms 
 Ommatthai 
Vernacular names 
Tamil : Oomatthai 
English : Dhatura (White flowering) Thorn –apple 
Tel  : Ummeth-tha 
Sans : Datura, unmattha 
Mal : Ummath-tham 
Hind : Dhatura 
Kan : Ummatte-gida 
Part used 
 Leaf, flower, unriped fruit, Seed 
Organoleptic character 
Taste (Suvai)   : Bitter (Kaippu) 
Potency (Thanmai)  : Hot (Veppam) 
Biotransformation (Pirivu) : Pungent (Karppu) 
Actions 
 Emetic (Vaanthiundakki) 
 Antispasmodic (Isivagattri) 
 Anodyne (Thuyaradakki) 
 Narcotic (Moorchaiundakki) 
General properties 
 fib<g<gcbiz<!uf<K!fzqosb<!uqv{Ll<Ohil<!
! uib<Gpqh<H{<!gm<cgT!liXr<gi{<!.!kQg<G{k<jks<!
! Oslk<kqz<!juk<kqzqmf<!kQVLk<Oki!mr<gtXl<!
! Dlk<jk!bqe<G{k<jk!Be<E/!
!! ! ! ! .!G{himl<!&zqjg!uGh<H!
 Dried leaf powder of dhatura, 32-100mg given internally for bronchial asthma 
 Fumigation produced with dhatura leaf act as expectorant and also releives 
breathing difficulty. 
 1-3 drops of dhatura leaf juice is given with jaggery for dog’s bite. 
 1-2 drops of dhatura leaf juice is used as ear drops for earache. 
 Seed paste prepared with cow’s ghee applied externally for hemorrhoids. 
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OOMATTHAI  IN OTHER MEDICINES 
1. MATHAKAJA KANDEERAVAM 
Indication : Diarrhoea 
Dosage :  Milagalavu (56mg) 
    - Siddha Vaithiya Thirattu, P.No. 69 
2. LAGUVATHA VIDHVAMSA MATHIRAI RASAM 
Indication : Kabam, Vadham, Akkinimantham, Soolai, Kirani. 
    - Anubava vaidhiya deva ragasiyam, P.No. 414 
 
TOXIC SYMPTOMS OF OOMATHAI 
Symptoms : 
  Dryness of mouth, difficulty in speaking, Dilatation of cutaneous blood vessels, 
Dilatation of the pupil, Dull vision, Delirium, Drowsiness, Dysphagia. 
Fatal Dose:    
  50 – 75 Seeds 
Antidote: 
• The tuber of Nelumbo nucifera is grounded with fermented rice water and made 
into paste its given internally. 
• Fer emetic effect, indigofera tinctoria bark grounded with fermented rice water 
made into paste it is given internally. After vomiting, Alangium salvifolium root 
bark is grounded with lemon juice made into paste taken internally. 
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DATURA METEL 
3.9.2. BOTANICAL ASPECT  
Taxonomical classification 
Kingdom :  Plant 
Division :  Tracheophyta 
Subdivision :  Spermatophytina 
Class  :  Magnolipsida 
Order  :  Solanales 
Family  :  Solanaceae 
Genus  :  Datura L. 
Species :  Datura metel L. 
Habitat 
 A herb grows in the waremer parts of the world, such as india. 
Description 
Habit 
 Shrub-like, annual herb with purple stem. 
Leaves 
 Simple, alternate, petiolate, entire or deeply lobed, glabrous showing unicostate 
reticulate venation and exstipulate. 
Stem 
 The stem is hollow, green and herbaceous with strong odour. 
Flower 
 Large, greenish white, bracteate, ebractiolate, pedicellate, complete, 
dichlamydeous, pentamerous, regular, actionomorphic, bisexual and hypogynous. 
Inflorescence 
 Solitary and axillary cyme 
Fruit 
 Spinescent capsule opening by four apical valves with persistant calyx. 
Seed 
 Endospermous. 
Root 
 Branched tap root 
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Chemical constituents: Phytochemicals 
Datura metel contains  
 Tropane alkaloids – Hyoscyamine, Scopolamine 
 Fastudine and fastunine. 
 Fastusic acid, alantoin 
 Ascorbic acid 
 Scopatone, Daturadiol, G-sitosterol, vanillin, N-trans-feruloyl-tyramine, 
scopoletin and Hyoscyamilactol. 
Therapeutic uses 
 The paste of roasted leaves is applied over the area to releive pain. 
 Dhatura seeds and leaves are used as antiasthmatic, antispasmodic, hypnotic and 
narcotic 
 Excess doses cause giddiness, drymouth, hallucinations 
 Hyoscyamine is used to provide symptomatic relief of various gastro intestinal 
disorders. 
 Atropine dilates the pupils and is used in eye surgery. 
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3.9.3. LATERAL RESEARCH: 
Medical importance of Datura fastuosa (syn: Datura metel) and Datura stramonium 
- A review IOSR Journal Of Pharmacy www.iosrphr.org (e)-ISSN: 2250-3013, (p)-
ISSN: 2319-4219 Volume 7, Issue 2 Version. 1 (Feb 2017), PP. 43-58 
Abstract:- The preliminary phytochemical investigation was performed on methanolic 
and hydroalcoholic extract of Datura fastuosa (syn: Datura metel) revealed the presence 
of alkaloids, tannins, cardiac glycosides, flavonoids, carbohydrates, amino acids and 
phenolic compounds, while, phytochemical analysis of Datura stramonium showed that it 
contained alkaloids, saponins, tannins, steroids, flavonoids, phenols and glycosides. The 
previous pharmacological studies of Datura fastuosa showed that it possessed 
antimicrobial insecticidal, antidiabetic, cytotoxic, antioxidant, antiinflammatory, 
analgesic, antipyretic, neurological, wound healing, reproductive and antispasmodic, 
while Datura stramonium exerted Antiepileptic, Anti-asthmatic, analgesic, antioxidant, 
antimicrobial, insecticidal, repellent and organophosphate protective effects.  
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3.10. HYGROPHILA AURICULATA – fQILt<tqQ <Q <Q <  
3.10.1. GUNAPADAM ASPECT 
Synonyms 
Ikkuram, Kagandam, Thuragathamoolam, Mundagam. 
Vernacular names 
Tamil : Neermulli 
English: Long leaved barleria 
Tel : Nirugobbi 
Sans : Kokilaksha 
Mal : Vayalchulli 
Hindi : Talmakhana 
Kan : Kollavalike 
Part used 
 Whole plant, flower, seed 
Organoleptic character 
Taste (Suvai)  : Sweet (Inippu), slightly bitter (Sirukaippu) 
Potency (Thanmai) : Coolant (Inippu) 
Biotransformation (Pirivu): Sweet (Inippu) 
Actions 
 Refrigerant (Kulirchiundakki) 
 Diuretic (Siruneer perukki) 
 Aphrodiasiac (Kamam perukki) 
 Tonic (Uramakki) 
General properties 
 uqf<KUlil<!kiKUlil<!OlgOvigf<okijzBl<!
! df<K!lkqsivl<!ypqBr<gi{<!.!uf<Kmzqz<!
! WxqbfQI!uQg<gl<!-xr<Gl<!-jth<HlXl<!
! %xqb!fQILt<tq!uqjkg<G!
! ! ! ! .!G{himl<!&zqjg!uGh<H!
Barleria seed cures swelling, leucorrhoea, diarrhoea and also enhances spermatogenesis. 
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Traditional uses 
 The whole plant of barleria is used to treat anaemia, dropsy, sinusitis and swelling. 
 The plant was extensively used in traditional system of medicine for various 
ailments like rheumatism, inflammation, jaundice, hepatic obstruction & pain. 
 It is antitumor, diuretic, free radical scavenging anti-inflammatory and antipyretic. 
 In ayurvedic system of medicine is used for the treatment of a number of 
conditions including premeham (diabetes) and athisaram (dysentry) 
 The entire plant and its ashes and roots can be used as cooling medicine and due 
to its diuretic properties, is very useful against cases of rheumatism dropsy, 
hepatic obstruction. 
 The seeds of the plant are diuretic and demulcent. 
 
NEERMULLI VIDHAI IN OTHER MEDICINES. 
1. SINTHAMANI MEVA 
Indication  :  Diarrhoea 
- Thanjai Vaidhiyaraja Sinthamani  
2. KABADA ILAGAM 
Indication : Seelkirani, Neerkirani, Moolakirani 
      - Bogar vaidhiyam – 700  
3. MAHA VILVATHI ILAGAM 
Dosage :  5-10gm 
Indication :  Diarrhoea, Indigestion 
     - Agathiyar Vaidhiya rathina churukam 
4. MAGUDATHI CHOORANAM 
Dosage :  Verukadi alavu (1250-1500mg) 
Adjuvant :  Honey, Curd, Buttermilk  
Indication  :  Diarrhoea, dysentry. 
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HYGROPHILA AURICULATA 
3.10.2. BOTANICAL ASPECT 
Taxonomical classification 
Kingdom :  Plant 
Division :  Tracheophyta 
Subdivision : Spermatophytina 
Class  :  Magnoliopsida 
Order  : Lamiales 
Family  :  Acanthaceae 
Genus  :  Hygrophila 
Species : Hygrophila auriculata 
Habitat 
 A herb growing in wet places. 
Description 
Habit 
 This is an annual herb or under shrub it grows to a height of about 60cms. 
Leaves 
 The leaves are elliptic- lanceolate and sessile.  The outer leaves of the whorl larger 
than others, each one with a yellow straight spine in its axil. 
Stem 
 Square and thickened at nodes, hairy. 
Flowers 
 4 pairs at each node, bracts leaf like, lower portion ciliate with long white hairs.  
Corolla purplish –blue, stamens -4, didynamous, filaments unequal. 
Fruit 
 Capsule oblong, seeds 4-8, with hygroscopical white hairs. 
Chemical constituents : Phytochemicals 
Hygrophila auriculata contains 
 Phytosterols, fatty acids, flavonoids, terpenoids and  glycosides 
 Lupenone, β- carotene, apigenin-7-o-glucuronide ascorbic acid, glucose, mannose, 
rhamnose, arbinose, maltose, myristic acid, oleic acid, palmitic acid, stearic acid, β-
sitosterol, histidine, phenylalanins, lysine, apigenin-7-o-glucoside, 3-methylnonacosane, 
asteracanthine, luteolin-7-rutinoside.  
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Two alkaloids, asteracanthine and asteracanthicine were reported from the seeds. 
Therapeutic uses 
 The seeds are ground into a paste and given in buttermilk for diarrhoea. 
 The seeds are used in treatment blood disorders gonorrhea and fever. 
 The tincture of the whole plant is beneficial in urinary affections, dysuria and 
painful micturation. 
 The leaves are tonic, aphrodisiac and useful in the treatement of diarrhoea, thirst, 
urinary calculi. 
 The oil extracted from the whole plant is antibacterial. 
 The roots are used in the form of decoction in rheumatism, gonorrhoea and 
hepatic obstruction. 
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3.10.3. LATERAL RESEARCH 
Evaluation of cytotoxic, analgesic, antidiarrheal, and phytochemical properties of 
Hygrophila spinosa (T. Anders) whole plant DOI 10.1515/jbcpp-2016-0103 
Abstract 
Background: Synthetic drugs are going to be replaced by plant-derived traditional drugs 
due to their cost effectiveness, relatively less harmfulness, and efficacy against multidrug 
resistance organisms. Hygrophila spinosa (Acanthaceae) has been used in a wide range of 
ailments including flatulence, diarrhea, dysentery, gonorrhea, and menorrhagia. 
Therefore, we investigated the cytotoxic, antinociceptive, and antidiarrheal effects of H. 
spinosa ethanol extract (EExHs). Methods: Preliminary phytochemical screening was 
accomplished by established methods modified in experimental protocol. EExHs was 
undertaken for cytotoxic 
assay by Brine shrimp lethality bioassay, antinociceptive action by acetic acid induced 
writhing test, and antidiarrheal activity by castor oil induced antidiarrheal test. Data were 
analyzed by GraphPad Prism 6.0 software using Dunnett’s test for multiple comparisons. 
Results: Reducing sugar, steroid, glycoside, tannin, alkaloid,saponins, and flavonoids 
were found to be present  in EExHs. Lethal concentration (LC50) of EExHs for brine 
shrimps was 50.59 µg/mL which was relatively lower than that of the standard drug 
vincristine sulfate. In acetic acid induced writhing test, oral administration of EExHs at 
three different doses (125, 250, and 500 mg/kg) decreased writhing in dose-dependent 
manner while the highest dose (500 mg/kg) achieved the maximum percentages of pain 
inhibition (58.8%). Diclofenac sodium (25 mg/kg) was used as a reference 
antinociceptive drug. The antidiarrheal action of EExHs was not found to be very 
promising for further use; however, the pure compounds from EExHs could be analyzed 
to justify the effects. Conclusions: This research demonstrates that the secondary 
metabolites guided cytotoxic and analgesic effects could be extensively studied in 
multiple models to confirm the effects. 
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3.11.  DISEASE REVIEW 
3.11.1. BEDHI – SIDDHA ASPECT 
PERUM KAZHICHAL 
Syn : Athisaram 
   Migukazhichal 
Iyal:  
 It is the increased frequency & liquidity of the stools, which could either formed 
or unformed.  The food materials are quickly emptied from the intestine resulting in 
increased frequency.  As a result the body is deprived of nourishment causing loss of 
weight & malnutrition problem. 
Noi varum vazhi 
1. Increased intake of Mapandam 
- Contaminated food 
- Oil & ghee 
- Decayed food materials 
- Food difficult to digest 
- Improperly cooked food 
2. Involving in increased sexual activities when there is Mantham 
3. Worm infestation 
Murkurikunangal 
1. Increased salivation 
2. Nausea 
3. Hiccup 
4. Belching 
5. Borborygmi 
6. Lower abdominal spasmodic pain 
7. Abdominal distension 
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Noi Enn: 8 types 
 Kutrangal -4 
 Extrinsic -4 
Kutrangal 
1. Vali 
2. Azhal 
3. Iyam 
4. Mukkutram 
Entrinsic 
1. Suram 
2. Thodam 
3. Bhayam 
4. Kuruthi 
VALI PERUMKAZHICHAL 
- Abdominal pricking pain like Soolai 
- Flatulence 
- Unformed stools 
- Indigestion 
- Sour belching 
- Diarrhoea with foul smell 
- Incontinence of urine 
AZHAL PERUMKAZHICHAL 
- Yellowish and frothy stools, dry in nature 
- Flatulence 
- Odema of limbs, emaciation of body 
- Fever 
- Pallor 
- Headache 
- Vomiting 
- Pain around umbilical area 
- Pain in stomach and anus 
- First blackish then frothy stools 
- Later bloody diarrhea also occur 
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IYYA PERUMKAZHICHAL 
- Diarrhoea with foul smell and froth 
- Diarhoea with pain 
- Sometimes with borborygmi and phlegm 
- Along with the diarrhea Suvai inmai (tastelessness) 
- Cough 
- Phlegm in chest 
- Perumoochu (dyspnea) 
- Tenesmus 
- Irritation all over the body 
MUKKUTRA PERUMKAZHICHAL 
- Iraichal 
- Diarrhoea with phlegm and blood 
- Phlegm in chest 
- Cough 
- Hiccup 
- Vomiting 
- Cold extremities 
- Noisy abdomen 
- Flatulence 
- Numbness all over the body 
SURA PERUMKAZHICHAL 
 This perumkazhichal is associated with suram 
THODA PERUMKAZHICHAL  
 According to siddha a cause for this disease is said to be birds when pass above 
babies or is the shadow of birds fall on the baby this disease will occur. 
BHAYA PERUMKAZHICHAL 
 This disease is caused due to increased emotional disturbances.  This can be 
avoided through various ways like meditation. 
KURUTHI PERUMKAZHICHAL 
 This is caused due to increased intake of sour and pungent food materials.  
Increased dose of mercury containing medicine or defective preparation can also cause 
this, plants like kundrimani, serankottai, sithiramoolam, moosambiram when given in 
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higher doses without proper purification and will cause perforation in stomach & hence 
produce bloody stools. 
Pothukurikunangal 
- Increased salivation 
- Anorexia 
- Indigestion 
- Sour belching 
- Hiccup 
- Pain in abdomen 
- Bloating abdomen 
- Frequency of stool 
- Lethargy 
- Dryness of skin 
- Tiredness 
- Depression 
- Cold extremities 
- Without proper medication it will leads to 
o Cramps 
o Feeble pulse 
o Oliguria 
o Patient remains conscious till death. 
Mukkutra Verupadukal 
 Due to abnormal food habits derangement of pitham and  vatham occurs. This 
increases udanavayu causing indigestion, salivation, hiccup, belching.  Derangement of 
abanavayu causing flatulence, borborygmi, increased evacuation.  Emaciation of 7 udal 
thathus occur resulting in perumkazhichal. 
Naadi nadai 
- Pithathil ushnam 
- Vathathil ushnam 
- Kapha pitham 
- Kapham 
- Pitham 
Urine : Decreased, yellowish red. 
Fecus : Yellow, black, whitish coloured watery stools. 
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TREATEMENT 
- Normalize the deranged digestive fire 
- Regularize the abanavayu 
- Appetizers and antidiarrhoeals can be given 
Decoctions 
1. Athividayam decoctions 
  Athividayam 
  Vilva pazham 
  Korai kizhangu 
  Iruveli ver 
Add 2 nazhi water prepare as decoction.  Then add thippili & chukku – 30-60 ml 
BD/TDS 
2. Mathulam pazhathol & chukku decoction.  Add some honey – 30-60 mlBD 
3. Thippiliathi kudineer : Azhalperumkazhichal 
4. Maramanchal kudineer 
Choornam 
1. Thayir chundi churnam 
2. Chundai vatral podi 
3. Annapodi 
4. Thaleesapathiri podi 
Vadagam 
1. Thaleesathi vadagam 
2. Pirandai vadagam 
3. Vazhai poo vadagam 
Pills 
1. Kabada pills 
2. Kattu vathi pills 
3. Oozhi pills 
4. Vajrakapada mathirai 
5. Jathikkai mathirai 
Parpa chendhoorams 
1. Ainthuppu parpam 
2. Uppu chendhooram 
3. Naga parpam 
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4. Pavazha parpam 
5. Nathai parpam 
6. Linga thuvar 
7. Muthu parpam 
8. Annabedi chendhooram 
Legiyam 
1. Ingi legiyam 
2. Jathikkai legiyam 
3. Vilvathi legiyam 
Manapagu 
1. Vilva manapagu 
2. Kudasa manapagu 
3. Chemparuthi manapagu 
Diet 
- Watery food substances 
- Barley water 
- Atthi pinchu 
- Two times cooked rice water 
- Butter milk 
- Avarai pinchu 
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3.11.2. MODERN ASPECT 
DIARRHOEA 
INTRODUCTION 
 Diarrhoea is defined as the passage of more than 200gm of stool daily, and 
measurement of stool volume is helpful in confirming this.  The most severe symptom in 
many patients is urgency of defecation and faecal incontinence is a common event in 
acute and chronic diarrhoeal illness. 
It may be divided into 2 types 
1. Acute diarrhoea 
2. Chronic (or) Relapsing diarrhoea. 
  Acute diarrhoea is extremely common and is usually due to faecal – oral 
transmission of bacteria or their toxins.  Chronic diarrhoea is increased frequency of 
defecation and loose, watery pellet stools. 
 
Epidemiology: 
 Death rate of 4.5 million in 1980 for gastroenteritis.  Diarrhoea remains the 
second leading cause of infant mortality (16%) often pneumonia (17%) in this age group.  
The majority of such cases occur in the developing world with over half of the recorded 
cases of childhood diarrhoea occurring in Africa and Asia with 96 million and 1.2 billion 
cases respectively, compared to only 480 million in the rest of the world. 
 Infectious diarrhoea resulted in about 0.7 million deaths in children under five 
years old in 2001 and 250 million last school days.  In the America’s diarrhoeal disease 
accounts for a total of 10% of death among children aged 1-59 months.  While in south 
east asia, it accounts for 31.3% of deaths.  It is estimated that around 21% of child 
mortalities in developing countries are due to diarrhoeal diseases. 
 World wide in 2004 approximately 2.5 billion cases of diarrhoea occurred which 
result in 1.5 million death among children under the age of five.  Greater than half of 
these were in Africa and South Asia. 
 In India accounts for 13% of all deaths in Indian children younger than 5 years. 
 There is significant morbidity associated with diarrhoea in children under 5 years 
of age.  Reducing mortality from diarrhoea is clinical to achieving the health care goals. 
Causes 
 Poor sanitation, open defecation is a leading cause of infectious diarrhoea leading 
to death. 
  
   63 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
 Contaminated water 
 Poor nutrition 
 Malabsorption 
 Inflammatory Bowel disease 
 Irritable bowel syndrome  
Other causes 
 Diarrhoea can be caused by chronic ethanol ingestion. 
 Ischemic bowel disease 
 Bile salt malabsorption 
 Harm one secreting tumours  Eg : serotonin can cause diarrhoea. 
 Viral infection such as rotavirus, enterovirus or a hepatic virus. 
 Bacterial infections like E-coli, Salmonella, Shigella can cause the disease. 
 
PATHOPHYSIOLOGY 
 Diarrhoea is an increase in the volume of stool or frequency of defecation.  It is 
one of the most common clinical signs of gastrointestinal disease, but also can reflect 
primary disorders outside of the digestive system.  Certainly, disorders affecting either  
the small or large bowel can lead to diarrhoea. 
 For many people, diarrhoea represents an occasional inconvenience or annoyance, 
yet atleast 2 million people in the world, mostly children, die from the consequences of 
diarrhoea each year. 
 Pathophysiology of diarrhoea have classified into,  
1. Secretory diarrhoea 
2. Osmotic diarrhoea 
3. Inflammatory diarrhoea 
4. Iatrogenic or Drug induced diarrhoea. 
Prevention: 
 By proper sanitation 
 Hand washing 
 Improved sanitation of drinking water 
 Vaccination (Rotavirus) 
 Proper nutrition 
 Breast feeding exclusively for 6 months after birth. 
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3.12. PHARMACEUTICAL REVIEW 
 
3.12.1. SIDDHA ASPECT OF THE FORMULATION 
PILL (MATHIRAI) 
DEFINITION OF PILL 
 The raw drugs are triturated with the juices of leaves or kudineer.  They are rolled 
into different sizes of pills, dried and stored. 
 
RULES OF TRITURATION 
 The ingredients should be first purified and  powdered into a find powder and then 
maserated with the prescribed juices or liquid one after the other in their order.  Each time 
it must be grinded till it becomes waxy in consistency does not adhere to the fingers or 
mortar and pestle, lastly it must be made into pills as prescribed and dried in shade. 
 
ADDITION OF AROMATIC INGREDIENTS 
 Aromatic ingredients were added just before 24mins (1 naazhigai) of pill rolled 
from finely grounded paste.  The aromatic ingredients added pills should allowed to dry 
in shade and keep them in a tightly closed container. 
SIZE AND SHAPE 
 Usually round in shape, there fore it also called as ‘Urundai’.  But it may differ in 
some preparations.   e.g. Urai mathirai.  The size, shape and weight of the pills should be 
made as said in the literature evidence. 
SHELF LIFE 
 1 year 
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3.12.2. MODERN ASPECT OF THE FORMULATION  
DEFINITION OF PILLS (MATHIRAI): 
 A tablet is a pharmaceutical dosage form it otherwise called as caplet.  Medicinal 
tablets are called as “pills”.   Originally “pills” referred specifically to a soft mass rolled 
into a ball shape, rather than a compressed powder. 
 As per Indian pharmacopeia 2007 defined the tablets are solid dosage forms each 
containing a unit dose of one or more medicaments.  They are anticipated for oral route.  
A tablet consists an active medicament with excipients which are in powder form are 
compressed or pressed into a solid  dosage form.  About two third drugs prescribed are in 
solid dosage form and tablets include half of them. 
Classification 
 As per IP 2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007). 
1. Uncoated Tablets 
This type of tablets contains single layer or more than one layer tablet consisting 
of active ingredient with  the excipients, no additional cover is applied onto it after the 
compression. 
2. Coated tablets 
 Coated types of tablets have an additional coating layer on it after the tablet was 
compressed, the coating layer of tablets formed with sugar, gums, resins, inactive or 
insoluble fillers, plasticisers, polyhydric alcohols, waxes. 
3. Dispersible tablets 
 These are the film coated or uncoated tablets because a uniform dispersion when 
suspended in water. 
4. Effervescent Tablets 
 These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce Co2, thus produced Co2 
will disintegrate the tablet so which dissolves in the solution to produce an suspension 
which was rapidly absorbed. 
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5. Modified-release tablets 
 These types of tablets are the coated or uncoated tablets which are designed in 
such a way that the rate or location of the active ingredient released is modified.  It 
includes enteric coated tablets, prolong release tablet or delay release tablet. 
A. Enteric- coated tablets 
 These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of methylacrylic 
acid and their esters or by coating with cellulose acetyl pthylate.  Ex. Erythromycin, 
NSAIDS. 
B. Prolonged –release tablets 
 These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a prolong 
duration of time and is available in systemic circulation  after administration. 
 
C. Delayed –release tablets. 
 This dosage form was planned to release the drug after some time delay or after 
the tablet has passed one part of the GIT into another.  All enteric coated tablets are type 
of delayed action tablet but all delayed action of tablets was not enteric or not intended to 
produce enteric action. 
6. Soluble tablets 
 These are coated or uncoated tablets which are planned to dissolve in water before 
they are administered. 
7.  Tablets for use in the mouth: 
 These are the tablet formulations which are planned to be show local action in the 
buccal cavity.  These include buccal tablet, sublingual tablets and troche or lozenges.  
Buccal tablets are placed in between the cheek and gingival.  Sublingual tablets are 
placed below the tongue. 
Eg : glyceryl trinitrate 
8.  Tablets for other routes of administration 
 These include implantable tablets and vaginal tablet.  These are inserted into the 
rectum or vagina for their local or systemic action. 
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4. MATERIALS AND METHODS 
4.1. PREPARATION OF THE DRUG : 
 Kattuvai Mathirai has been selected from the classical siddha literature Sikitcha 
Rathna deepam yennum vaidhiya nool, Page No:158 
 Ingredients of the test drug are Lingam, Ilavampisin, Athividayam, Sathikkai, 
Sathipathiri, Vilvapazham, Kaichukkatty, Kirambu, Oomathi, Neermulli. 
 
COLLECTION OF THE DRUGS : 
 The raw drugs lingam, Ilavampisin, Athividayam, Sathikkai, Sathipathiri, 
Vilvapazham, Kaichukkatty, Kirambu, Oomathai, Neermulli were purchased from 
authorized drug store in Nagercoil at Kanyakumari district. 
 
IDENTIFICATION AND AUTHENTICATION OF DRUGS : 
 The raw materials were identified and authenticated by the experts of PG 
Gunapadam Dept, Government Siddha Medical College, Tirunelveli. 
 The identified raw materials were conserved in the laboratory of PG Gunapadam, 
Government Siddha Medical College, Tirunelveli. 
 
INGREDIENTS: 
1. Lingam (Red sulphide of mercury) -  976mg (2 panavedai) 
2. Ilavampisin (Gum of Bombaxmalabaricum Linn) 7.65gm (1 1/2 Kalanju) 
3. Athividayam (Aconitum heterophyllum wall-ex.Royle) - 7.65gm (1 1/2 Kalanju) 
4. Sathikkai (Mylistica fragrans Houtt) - 7.65 gm (1 1/2 kalanju) 
5. Sathipatthiri (Myristica fragrans Houtt) - 7.65gm (1 1/2 Kalanju) 
6. Vilva pazham (Fruit of Aegle marmelos Linn) - 15.3 gm (3 Kalanju) 
7. Kaichukatty (Extract from Acacia catechu Linn) - 7.65 gm (1 1/2 Kalanju) 
8. Kirambu (Syzygium aromaticum Linn) - 7.65gm (1 1/2 Kalanju) 
9. Leaf juice of Datura metal Linn - Quantity Sufficient  
10. Hygrophila auriculata seeds Linn - Quantity Sufficient 
 
PURIFICATION OF INGREDIENTS: 
1. Lingam: (Red sulphide of mercury) 
 Impure Lingam can be subjected to powdered and saturated with equal parts of 
lime juice, Cow’s Milk, Acalipha indica juice. 
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2. Ilavampisin: (Gum of Bombox malabaricum) 
 Gum is dissolved in water then filtered and dried in sunlight. 
3. Athividayam: (Aconitum heterophyllum) 
 Outer layer is scrapped out and made into pieces & allow to dry in sunlight. 
4. Sathikkai: (Myristica fragrans) 
 Scrap the outer skin and roast it in ghee  
5. Sathipathiri : (Myristica fragrans) 
 Sathipathiri is allowed to dry in sunlight. 
6. Vilvapazham: (Fruit of Aegle marmelos) 
 Remove the outer shell of the fruit. 
7. Kaichukkatty: (Extract from Acacia catechu) 
 First Kaichukatty was powdered and it should be dissolved in distilled water, until 
it became saturated and filtered then allowed to dry completely under sunlight. It takes for 
complete drying. Then the purified Kaichukatty was made into fine powder. 
8. Kirambu : (Syzygium aromaticum) 
 Kirambu is allowed to dry in sunlight. 
9. Neermulli : (Hygrophila auriculata) 
  Clean dust, sand and  infected seeds. 
10. Oomathai: (Datura metal) 
  Remove riped and infected  leaves. 
 
METHOD OF PREPARATION: 
 All the above purified ingredients are powdered individually, placed in mortar & 
pestil and triturated well with the leaf juice of datura metal for 3 hours and then measure 
the weight of paste. Add 3 fold of Hygrophilla auriculata seed in propation to that paste 
and again triturated with the above juice for 3 hours and made into pill upto one kundri. 
 
SHELF LIFE : 
 1 Year 
 
METHODS OF APPLICATIONS: 
Adjuvants : Ghee 
Dosage : (Kundrimaniyalavu – 130mg) One pill morning & evening  
 
INDICATION:  
  All types of Bedhi 
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Fig : 1 Ingredients of Kattuvai Mathirai 
BEFORE PURIFICATION 
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Fig : 1 Ingredients of Kattuvai Mathirai 
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Fig : 1 Ingredients of Kattuvai Mathirai 
AFTER  PURIFICATION 
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On Processing 
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4.2. STANDARDIZATION OF THE DRUG: 
  The standardization of the drug is essential to exhibit the purity, quality and 
quantity of the drug. This is basically done by chemical, physico-chemical and 
instrumental analysis. 
4.2.1. PHYSICAL ANALYSIS 
TESTING PHYSICAL CHARACTERIZATION OF SAMPLE: 
Colour Examination:  
Ten tablets were taken into watch glasses and positioned against white back ground in 
white tube light. Its colour was observed by naked eye and note in results. 
Odour examination: 
 Ten numbers of tablets were smelled individually. The time interval among two 
smelling was kept two minutes to overturn the effect of previous smelling. Odour of 
KATTUVAI MATHIRAI.  tablet was noted in results table.  
Size examination: 
 The diameter of ten tablets was measured by Vernier caliper. The mean value of 
diameter was noted. (Lohar DR-Protocol for testing ASU drugs) 
Weight Variation Test:  
 It was carried out to make sure that, each number of tablets contains the proper 
amount of drug. The test was carried out by weighing the 20 tablets individually using 
analytical balance, then the average weight was calculated, and comparing the individual 
tablet weights to the average. (Sukalyan Sengupta 1988) 
 
  The percentage of weight variation is calculated by using this formula.  
% of wt. variation =    Individual wt. – Average wt.  x 100 
   Average wt. 
 
Table. 1   Weight Variation limits  of Tablets (IP) 
Average weight   of tablets Maximum percentage of weight  difference  allowed 
80mg or less + 10.0 
Between 80mg and 250mg + 7.5 
250mg and more + 5.0 
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Accepted tablet:  
 Weight Variation limits of the sample not more than two tablets are outside the 
percentage limit and no tablet differs by more than two times the percentage limit 
according to the above table. 
Suspected tablet:  
 Suspected tablet variation was not more than six tablets are outside the percentage 
limit and no tablet differs by more than two times the percentage limit according to the 
table. 
Rejected tablets:  
 When a tablet weight variation test results showed rejected tablets mean in that 
test sample one tablet differs by more than two times the percentage limit according to the 
table or More than six tablets are outside the percentage limit. (Sukalyan Sengupta, 1988) 
Solubility:  
 A pinch of the sample was taken in a dry test tube and shaken well with distilled 
water.  A little amount of the sample is shaken well with con HCl and then Con.H2SO4. 
Test sample Solubility was observed.  
pH Value: 
 Potentiometrically pH value was determined by a glass electrode and a suitable 
pH meter. The pH of the KATTUVAI MATHIRAI tablet was written in results column. 
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4.2.2. PHYSICO CHEMICAL ANALYSIS 
LOSS ON DRYING (INDIAN PHARMOCOEPIA, 1996) 
               Loss on drying is the loss in percentage w/w resulting from water and volatile 
matter of any kind that can be driven off under a specified condition. A glass stopper, 
shallow weighing bottle was weighed accurately and the quantity of the sample as 
specified was transferred to the bottle was weighed accurately and the quantity of the 
sample as specified was transferred to the bottle covered and weighed. The sample was 
distributed evenly and the bottle was placed in the drying chamber. The sample was then 
dried for a specific period of time, and the bottle was removed from the chamber and 
allowed to cool at room temperature in a desiccators before weighing. 
TOTAL ASH: 
       Two grams of ground air dried powder of KATTUVAI MATHIRAI  was accurately 
weighed in a previously ignited and tared silica crucible. The drug was gradually ignited 
by raising the temperature to 450oC until it was white. The sample was cooled in a 
desiccators and weighed. The percentage of total ash was calculated with reference to air-
dried drug. 
a)Acid insoluble ash 
              The ash was boiled with 25ml of 2M hydrochloric acid for 5 minutes, the 
insoluble matter was collected on an ash less filter paper, washed with hot water, ignited 
cooled in a desiccators, and weighed. The percentage of acid insoluble ash calculated 
with reference to the air-dried drug. 
b)Water soluble extractive 
               Proceed as directed for the determination of Alcohol-soluble extractive , using 
chloroform water instead of ethanol. 
c)Alcohol soluble extractive 
                Macerate 5g of the air dried drug, coarsely powdered, with 100ml of alcohol of 
the specified strength in a closed flask for 24 hrs, shaking frequently during six hours and 
allowing to stand for eighteen hours. Filter rapidly, taking precautions against loss of 
solvent, evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, 
and dry at 105o, to constant weight. Calculate the percentage of alcohol-soluble extractive 
with reference to the air-dried drug. 
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TABLET DISINTEGRATION TEST:  
 Each KATTUVAI MATHIRAI tablet was placed in each of the six tubes of the 
basket present in the disintegration apparatus. The apparatus was operated by using water 
as the immersion fluid maintained at 35-39 °C. At the end of the 30 min, the basket is 
lifted from the fluid and the state of the tablet is observed. The disintegration time of 
Kattuvai  Mathirai was recorded.(Loher Dr). 
 
MICROBIAL LIMIT TEST OF KATTUVAI MATHIRAI  
1. Evaluation of Total Aerobic Bacterial Count 
1.1. Preparation of  Sample for Experimental Work 
Weighed 10 gm of the homogenized drug sample aseptically and dissolved in 10 
ml of sterile water and made up to 100 ml with the sterile water. The insoluble drug 
product was suspended in 100 ml of buffered sodium chloride-peptone solution (pH 7.0).   
1.2. Serial dilution of Sample 
 A serial dilution is the dilution of a sample, in 10-fold dilutions. From the sample, 1 
ml of the sample was added to 9 ml of sterile distilled water and mixed it well. This 
dilution was denoted as 10-1 dilution. From this dilution, one ml was taken from that 
mixture is added to 9 ml, and designated as 10-2 dilution. The same procedure was 
repeated up to 10-4. 
1.3. Isolation of Total Viable Aerobic Microbial Count 
1.3.1. Isolation of Bacteria by Plate Count Method 
  In this test, the bacteria in sample were made to grow as colonies, by inoculating a 
known volume of sample into a solidifiable nutrient medium (Casein Soybean Digest agar 
or Nutrient agar medium) in petridish. The agar plate was prepared by mixing growth 
medium with agar and then sterilized by autoclaving. Once the agar was cooled to 45oC, 
approximately 15 to 20 ml of medium was poured into a sterile Petri dish under aseptic 
condition and left to solidify for 15 minutes. After solidification, each plate was smear 
with 0.1 ml of sample from the dilution of 10-1 and 10-2. After inoculations, all the plates 
were incubated at 37oC for 24 hours. After incubation, the bacterial colonies were 
developed as visible to the naked eye and the number of colonies on a plate was counted 
using Quebec Colony Counter. Plates with an average of from 30 to 300 colonies of the 
target bacterium were selected for colony count. Because of the statistical problems, 
plates with lower than 30 colonies greater than 300 colonies were rejected     
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1.3.1.1. Composition of Nutrient Agar Media 
Peptone   : 5.0 gm  
Sodium chloride  : 5.0 gm  
Beef extract   : 1.5 gm 
 Yeast extract   : 1.5 gm 
Agar    : 15.0 gm 
Distilled water   : 1000 ml  
 pH ( at 25°C)   : 7.4±0.2 
 
1.3.2. Isolation of Fungi 
  From each of the above prepared samples, 0.1 ml of sample was transferred to 
Sabouraud Dextrose agar (SDA) prepared with Chloramphenicol. The plates were then 
incubated for 5 days at room temperature (20 to 25°C). After incubation, the fungal 
colonies were observed and calculated.   
 
1.3.2.1. Composition of SDA 
Dextrose   ; 40 gm 
Peptone   : 10 gm 
Agar   : 15 gm 
Distilled water : 1000 ml 
 
1.4. Evaluation of Antimicrobial Activity of Drug 
 Antimicrobial activity was performed by disc diffusion method on agar. 
1.4.1 Preparation of drug extracts solutions for the experiment  
The dried drugs were weighed and dissolved in sterile distilled water to prepare 
appropriate dilution to get required concentrations of about 10, 20 and 30µg/ml. They 
were kept under refrigerated condition unless they were used for the experiment. 
1.4.2. Procedure for the Agar Well Diffusion Test 
 The antibacterial screening of the drugs were carried out by determining the zone 
of inhibition using disc diffusion method. All the drug extracts were tested against four 
pathogenic bacterial strains of gram positive and gram negative organism by disc 
diffusion method. 
1.4.3. Bacterial Inoculums Preparation 
 Inoculums of Staphylococcus mutants, Staphylococcus aureus, Escherichia coli, 
Klebsiella pneumoniae, Proteus vulgaris, and Bacillus substilis were prepared in nutrient 
broth medium and kept for incubation at 37°C for 8 hrs. 
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1.4.4. Agar well-diffusion method  
This method was followed to determine the antimicrobial activity. Muller-Hinton 
Agar media plates were swabbed (sterile cotton swabs) with 8 hour old - broth culture of 
respective bacteria. After inoculation, wells with the size of 10 mm diameter and about 2 
cm a part were made in each of these plates using sterile cork borer. Stock solution of 
each drug extract was prepared at a concentration of 1 mg/ml in water. About 100 µl of 
different concentrations of drug solvent extracts were added into the wells and allowed to 
diffuse at room temperature for 2 hrs. The plates were incubated at 37°C for 24 hrs. After 
incubation, the diameter of the inhibition zone (mm) was measured and the activity index 
was also calculated.  
 1.4.4.1. Composition of Muller Hinton Agar Media 
 Beef Extract     : 02.00 gm 
 Acid Hydrolysate of Casein   : 17.50 gm 
 Starch      : 01.50 gm 
 Agar     : 17.00 gm 
1.5. Evaluation of Specified Microorganisms  
1.5.1. Isolation & Identification of Escherichia coli 
One ml of the prepared sample was added in a sterile screw-capped container 
containing 50 ml of nutrient broth and mixed well. Then, it was allowed to stand for 1 
hour and mixed well again. After one hour, the screw caps of the bottle was loosened and 
incubated at 37º for 18 to 24 hours. 
1.5.1.2. Primary Test 
From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into a tube containing 5 ml of Mac- Conkey broth. Inoculated tubes were 
incubated in a water-bath at 36º to 38º for 48 hours.  
1.5.1.3. Secondary Test 
From the primary test, 1.0 ml of the enrichment culture was taken and transferred 
aseptically in to 5 ml of peptone water. It was then incubated in a water-bath at 43.5º to 
44.5º C for 24 hours and observed the tubes for acid and gas. Then, the culture was 
subjected to biochemical tests of imvic and the results were observed and correlated.       
1.5.1.4. Alternative test  
It was done by a loop full of enriched culture in the primary test was streaked on a 
sterile Mac-Conkey agar medium. Then, the plates were inverted and incubated at 37 º C 
for 24 hours. After incubation, the pink or brick red color colonies were examined and 
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transfer them individually into the surface of Eosin Methylene Blue agar medium (EMB), 
on Petri dishes. Inoculated plates were inverted and incubated at 37 º C for 24 hours. 
After incubation, the colonies on medium were checked for their color appearance like 
green metallic sheen under reflected light. The colonies were subjected to confirmation 
by further suitable cultural and biochemical tests. 
1.5.1.5. Components of Eosin Methylene Blue Agar Media 
Pancreatic digest of gelatin   : 10.0 g 
Dibasic potassium phosphate   : 2.0 g 
Lactose      : 10.0 g 
Eosin Y      : 400 mg 
Methylene blue    : 65 mg 
Agar       : 15.0 g 
Distilled water     : 1000 ml 
1.5.1.6. Components of Eosin Methylene Blue Agar Media 
Pancreatic digest of gelatin    : 10.0 g 
Dibasic potassium phosphate   :  2.0 g 
Agar       : 15.0 g 
Lactose      : 10.0 g 
Eosin Y      : 400 mg 
Methylene blue     : 65 mg 
Distilled water     : 1000 ml 
1.5.2. Isolation & Identification of Salmonella sp.  
One ml of the prepared sample was added in a sterile screw-capped container 
containing 100 ml of nutrient broth and mixed well. Then, it was allowed to stand for 1 
hour and mixed well again. After one hour, the screw caps of the bottle was loosened and 
incubated at 37º for 18 to 24 hours. 
1.5.2.1. Primary Test  
From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into a tube containing 10 ml of Selenite F broth. Inoculated tubes were 
incubated in a water-bath at 36º to 38º for 48 hours. After incubation, the culture was 
subcultured on two of the agar media namely Bismuth sulphate agar and Deoxy cholate 
citrate agar and incubated the plates at 36º to 38º for 18 to 24 hours. After incubation, 
colonies were observed on the medium and confirmed the genus Salmonella based on 
guidelines. 
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1.5.2.2. Secondary test 
The suspected colonies of the primary test were subcultured on the slant of triple 
sugar-iron agar in test tube and in urea broth. Both media were incubated at 37ºC for 24 
hours. After incubation, the results were observed according to the development of color 
change and acid / gas in media.  The presence of Salmonella was confirmed by 
agglutination tests. 
1.5.2.3. Composition of Salmonella Shigella Agar Media 
Beef Extract    : 5.0 gm 
Enzymatic Digest of Casein  : 2.5 g 
Enzymatic Digest of Animal Tissue : 2.5 gm 
Lactose    : 10 gm 
Bile salts    : 8.5 gm 
Sodium Citrate    : 8.5 gm 
Ferric Citrate    : 1.0 gm 
Brilliant Green   : 0.00033 gm 
Neutral Red    : 0.025 
Agar     : 13.5 gm 
Distilled water    : 1000 ml 
 1.5.3. Isolation and Identification of Pseudomonas aeruginosa  
From the above prepared enrichment culture, 1.0 ml was taken and transferred 
aseptically into 100 ml of fluid soyabean-casein digest medium and mixed well.  The 
inoculated tubes were incubated at 37º C for 24 hours. After incubation, the growth of 
bacteria was checked. From this, a loop full of culture was streaked on the surface of 
Cetrimide agar medium and Pseudomonas Isolation Agar medium and incubated at 
incubated at 37º C for 24 hours. After incubation, the colonies from the agar surface of 
these two media were checked for detection of fluorescein and pyocyanin. 
1.5.3.1. Composition of Cetrimide Agar Media 
Pancreatic digest of gelatin   : 20.0 g 
Magnesium chloride    : 1.4 g 
Potassium sulphate    : 10.0 g 
Cetrimide     : 0.3 g 
Agar      : 13.6 g 
Glycerin     : 10.0 g 
Distilled Water t   : 1000 ml 
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1.5.4. Isolation and Identification of Staphylococcus aureus 
From the above prepared enrichment culture, a loop full of culture was taken and 
transferred aseptically on Mannitol salt agar and incubated at 37º C for 24 hours.. After 
incubation, the colonies were subjected to confirmation by hem agglutination test.  
 
1.5.4.1. Composition of Mannitol Salt Agar Media 
Pancreatic digest of gelatin   : 5.0 g 
Peptic digest of animal tissue  : 5.0 g 
Beef extract     : 1.0 g 
D-Mannitol     : 10.0 g 
Sodium chloride    : 75.0 g 
Agar      : 15.0 g 
Phenol red     : 25 mg 
Distilled Water    : 1000 ml 
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4.2.3. BIO CHEMICAL ANALYSIS 
PROCEDURE: 
  5gms of  the drug was wighted accurately and placed in a 250ml clean beaker. 
Then 50ml of distilled water is added and dissolved well. Then it is boilded well for about 
10 minutes. It is cooled and filtered in a 100ml volumetric flask and then it is make up to 
100ml with distilled water. This fluid is taken for analysis. 
 
QUALITATIVE ANALYSIS FOR BASIC RADICALS: 
Test for Calcium: 
 2ml of the above prepared extract is taken in a clean test tube. To this add 2ml of 
4% Ammonium oxalate solution. Formation of white precipitate indicates the presence of 
calcium. 
Test for Iron (Ferric): 
The extract is acidified with glacial acetic acid and potassium ferro 
cyanide.absence of blue colour indicates the absence of ferric iron. 
Test for Iron (Ferrous): 
 The extract is treated with concentrated Nitric acid and ammonium thio-cyanate 
solution. Formation of blood red colour indicates the presence of ferrous iron. 
Test for zinc: 
The extract is treated with potassium ferro-cyanide. Gives absence of white 
precipitate indicates the absence of zinc. 
 
QUALITATIVE ANALYSIS FOR ACIDIC RADICALS: 
Test for Sulphate: 
 2ml of extract is added to 5% barium chloride solution. Formation of white 
precipitate indicates the presence of sulphate. 
Test for Chloride: 
 The extract is treated with silver nitrate solution. Formation of white precipitate 
indicates the presence of chloride. 
Test for Phosphate: 
 The extract is treated with ammonium molybdate and concentrated nitric acid. 
Formation of yellow precipitate indicates the presence of phosphate. 
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Test for carbonate: 
On treating the extract with concentrated Hydrochloric acid giving absence of 
brisk effervescence indicates the absence of carbonate. 
Test for starch: 
 The extract is added with weak iodine solution. Formation of blue colour indicates 
the presence of starch. 
Test for albumin: 
The extract is treated with Esbach’s reagent. Gives absence of formation of yellow 
precipitate indicates the absence of albumin. 
Test for tannic acid: 
The extract is treated with ferric chloride.Gives absence of formation of bluish 
black precipitate indicates the absence of tannic acid. 
Test for unsaturation: 
 The extract is treated with potassium permanganate solution. The dis-
colourization of potassium permanganate indicates the presence of unsaturated 
compounds. 
Test for the reducing sugar: 
 5ml of Benedict`s qualitative solution is taken in a test tube and allowed to boil 
for 2 minutes and added 8-10 drops of the extract and again boil it for 2 minutes. Any 
colour change indicates the presence of reducing sugar. 
Test for amino acid: 
 One or two drops of the extract is placed on a filter paper and dried it well. After 
drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation of violet 
colour indicates the presence of amino acid 
 
4.2.4. PHYTOCHEMICAL ANALYSIS OF KATTUVAI MATHIRAI 
The siddha preparation KATTUVAI MATHIRAI was prepared and used for 
phytochemical analysis.  Preliminary test, on the siddha preparation KATTUVAI 
MATHIRAI was carried out for the presence of alkaloids, carbohydrates, glycosides, 
phytosterols, saponins, tannins, phenolic compounds, proteins and free amino acids, 
flavanoids, lignin, fixed oils and fats. The methods adopted for the estimation are as 
follows: 
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Test for Alkaloids (Evans, 1997)  
A small segment of the siddha preparation KATTUVAI MATHIRAI was mixed 
separately with a few drops of dilute hydrochloric acid and filtered. The filtrates were 
tested carefully with various alkaloidal reagents as follows:  
a) Mayer’s test (Evans, 1997):  
  To a few ml of filtrate, a drop of Mayer’s reagent is added by the side of the test 
tube. A white or creamy precipitate indicates that the test as positive.  
b) Hager’s test (Wagner et al., 1996):  
  To a few ml of filtrate, one to 2ml of Hager’s reagent is added. A prominent 
yellow precipitate indicates the test as positive.  
c) Dragendorff’s test (Waldi, 1965):  
  To a few ml of filtrate, one to 2ml of Dragendorff’s reagent is added. A prominent 
yellow precipitate indicates the test as positive.  
Test for Carbohydrates (Ramakrishnan et al., 1994)  
A small quantity of siddha preparation KATTUVAI MATHIRAI was dissolved 
separately in 5ml of distilled water and filtered. The filtrate was subjected to Molisch’s 
test to detect the presence of carbohydrates. Filtrate was treated with 2-3 drops of 1% 
alcoholic alpha naphthol solution and 2ml of concentrated sulphuric acid was added along 
the sides of the test tube. Appearance of brown ring at the junction of 2 layers shows the 
presence of carbohydrates. 
Test for Glycosides  
The siddha preparation KATTUVAI MATHIRAI was hydrolyzed with hydrochloric 
acid for few h on a water bath and the hydrolysate was subjected to Legal’s and 
Borntrager’s test to detect the presence of different glycosides.  
(a) Legal’s Test:  
  To the hydrolysate, one ml of pyridine and few drops of sodium nitro prusside 
solution were added and then it was made alkaline with sodium hydroxide solution. 
Appearance of pink to red color shows the presence of glycosides and aglycones.  
(b) Borntrager’s Test: 
  Hydrolysate was treated with chloroform and the chloroform layer was separated. 
To this equal quantity of dilute ammonia solution was added. Ammoniacal layer acquires 
pink color, shows the presence of glycosides (Evans, 1997).  
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Test for Phytosterols (Finar, 1986)  
(a) Liebermann Burchard Test:  
  Small amount of the siddha preparation KATTUVAI MATHIRAI was dissolved 
with 3ml of acetic anhydride, a few drops of glacial acetic acid and followed by the 
addition of few drops of concentrated sulphuric acid. Appearance of bluish green color 
shows the presence of phytosterols.  
(b) Salkowski Test:  
  Small quantities of the siddha preparation KATTUVAI MATHIRAI were dissolved 
in chloroform separately. This chloroform solution was added with few drops of 
concentrated sulphuric acid. The appearance of bluish green color shows the presence of 
phytosterols.  
Test for Flavanoids  
(a) Shinoda’s Test:  
  Small quantity of siddha preparation KATTUVAI MATHIRAI  was treated with 
alcohol to that a piece of magnesium was added followed by an addition of concentrated 
hydrochloric acid drop wise and heated. Appearance of magenta color shows the presence 
of flavanoids (Harborne, 1984).  
(b) Florescence Test: Small quantity of KATTUVAI MATHIRAI  was dissolved 
separately in alcohol and a drop of that extract was placed on Whatman filter paper and 
observed under UV light. Florescence indicates the presence of flavanoids.  
Test for Tannins (Mace, 1963)  
Small quantities of siddha preparation KATTUVAI MATHIRAI was dissolved 
separately in water and tested for the presence of phenolic compound and tannins. In the 
process of testing and treating, the following observations were noted:  
a) Dilute ferric chloride solution (5%) gives a dark green color. 38  
b) 10% aqueous potassium dichromate solution gives yellowish brown precipitate.  
c) 10% lead acetate solution gives a white precipitate.  
Test for Proteins and Free Amino Acids (Fisher, 1968; Ruthmann, 1970)  
Small quantities of various siddha preparation KATTUVAI MATHIRAI  was 
dissolved in few ml of water and the following reaction were carried out  
(a) Millon’s Test : To 2ml of filtrate, few drops of Millon’s reagent were added. A white 
precipitate indicates the presence of proteins (Rasch and Swift, 1960).  
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(b) Ninhydrin Test: To 2ml of filtrate 2 drops of ninhydrin solution was added. A 
characteristic purple color indicates the presence of amino acids (Yasma and Ichikawa, 
1953).  
(c) Biuret Test: An aliquot of 2ml of filtrate was treated with a drop of 2% copper 
sulphate solution. To this, 1ml of ethanol (95%) was added, followed by excess of 
potassium hydroxide pellets, Pink color in the ethanol layer indicates the presence of 
protein (Gahan, 1984).  
 
Tests for Fixed oils and Fats  
(a) Spot Test:  
  A small quantity of siddha preparation KATTUVAI MATHIRAI  was placed 
between 2 filter papers. Oil stains produced with any extract shows the presence of fats 
and fixed oils in the KATTUVAI MATHIRAI  (Harborne, 1984).  
 (b) Saponification Test:  
  A small quantity of siddha preparation KATTUVAI MATHIRAI  was treated with 
few drops of 0.5N alcoholic potassium hydroxide along with 2 to 3 drops of 
phenolphthalein. Later the mixture is refluxed for about 2h. Soap formation indicates the 
presence of fats and fixed oils in the KATTUVAI MATHIRAI . 
Tests for Lignin  
Small quantities of KATTUVAI MATHIRAI  was dissolved separately in few ml of 
alcoholic solution of hydrochloric acid and phloroglucinol gives red color, which shows 
lignin is present.  
Test for Saponins (Kokate, 1999)  
Frothing Test:  
  The siddha preparation KATTUVAI MATHIRAI  was diluted separately 
with 20ml of distilled water and it was agitated on a graduated cylinder for 15min. 
Absence of the foam formation shows the devoid of saponins.  
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4.2.5. INSTRUMENTAL ANALYSIS 
Fig. No. 1   SCANNING ELECTRON MICROSCOPE (SEM) 
 
  The microstructure of the powders was examined using a Hitachi S 3000H 
scanning electron microscope  
Introduction: 
  The scanning Electron Microscope is one of the most versatile instruments 
available for the examination and analysis of the micro structural characteristics of solid 
objects. The primary reason for the SEM’s usefulness is the high resolution which can be 
obtained when bulk objects are examined; values of the order of 5nm (50degreeA) are 
usually quoted for commercial instruments. Advanced research instruments have been 
described which have achieved resolutions of about 2.5nm (25 degree A). Any solid 
material can be studied. Sample size is limited to specimens less than about 10µm in 
diameter 
Principle:  
  The beam is then rastered over the specimen in synchronism with the beam of a 
cathode ray tube display screen. The eleastically scattered secondary electrons are emitted 
from the sample surface and collected by a scintillator, the signal from which is used to 
modulate the brightness of the cathode ray tube. In this way the secondary electron 
emission from the sample is used to form an image on the CRT display screen. 
(Goldstein, et. al., 1992) 
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SEM MECHANISM 
Procedure: 
  An electron beam passing through an evacuated column is focused by 
electromagnetic lenses onto the specimen surface. Since an electron is a charged particle, 
it has a strong interaction with the specimen (due to coulomb interaction).So when an 
electron beam images on a specimen, it is scattered by atomic layers near the surface of 
the specimen. As a result, the direction of electron motion changes and its energy is 
partially lost. Once an incident electron (primary electron) enters a substance, its direction 
of motion is influenced by various obstructions (multiple scattering), and follows a 
complicated trajectory which is far from a straight line. Also, when electrons with the 
same energy are incident on the specimen surface, a portion of electrons is reflected in the 
opposite direction (back scattered) and the remainder is absorbed by the specimen 
(exciting X- rays or other quanta in the process). If the specimen issufficiently thin, the 
electron can pass all the way through the specimen (transmitted electrons, scattered or 
non-scattered). 
  The depth at which various signals are generated due to electron beam – specimen 
interaction indicates the diffusion area of the signals in the specimen in addition to the 
local chemistry of the specimen. Secondary electrons mainly indicate information about 
the surface of a specimen. Since secondary electrons do not diffuse much inside the 
specimen, they are most suitable for observing the fine-structures of the specimen surface. 
That is to say, sharp scanning images with high resolution can be expected from 
secondary electrons, because of the smaller influence on resolution by their diffusion.  
  As the incident electron energy increases, the probability of incident electrons 
Colliding with elemental components of the specimen and releasing secondary electrons 
also increases. In other words, as the incident energy increases, the emission of electrons 
from the specimen also increases. However, as the energy increases beyond a certain 
level, the incident electrons penetrate deeper into the specimen with the result that the 
specimen derived electrons use up most of their energy to reach the specimen surface. 
Consequently, the electron emission yield decreases. Therefore, the peak secondary 
electron emission yield occurs at a specific entry level of the incident electrons. 
  In order to verify the existence of a substance and recognize its shape, the image 
contrast must be well defined. In other words, even if a system boasts extremely high 
resolution, if image contrast is poor, it would be extremely difficult to determine the 
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existence of a substance, let alone recognize its shape. Another important feature of the 
SEM is the three-dimensional appearance of the specimen image, which is a direct result 
of the large depth of field.  
Applications: 
  The SEM is capable of examining objects at very low magnification. This feature 
is useful in viewing particle size and shape of any composition at various stages of 
preparation in Siddha system as well as other fields.The large depth of field available in 
the SEM makes it possible to observe 3-dimensional objects in stereo. Today, a majority 
of SEM facilities are equipped with X-ray analytical capabilities. Thus topographic 
crystallographic and compositional information can be obtained rapidly, efficiently and 
simultaneously from the same area. 
  The author was chosen this analysis for detecting Particle size of the classical 
Siddha herbo-mineral drug KATTUVAI MATHIRAI. SEM results of KATTUVAI 
MATHIRAI were represented in results section. 
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Fig. No. 2 FOURIER TRANSFORM-INFRA RED SPECTROSCOPY       
(FT-IR) 
 
 
 
Introduction: 
  Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure .The spectral bands can be assigned to different vibrational modes of 
the molecule. The various functional groups present in the molecule can be assigned by a 
comparison of the spectra with characteristic functional group frequencies. As the 
positions of the bands are directly related to the strength of the chemical bond, a large 
number of investigations including intermolecular interactions, phase transitions and 
chemical kinetics can be carried out using this branch of spectroscopy. In IR 
spectroscopy, the resonance absorption is made possible by the change in dipole moment 
accompanying the vibrational transition. The Infrared spectrum originates from the 
vibrational motion of the molecule. The vibrational frequencies are a kind of fingerprint 
of the compounds. This property is used for characterization of organic, inorganic and 
biological compounds. The band intensities are proportional to the concentration of the 
compound and hence qualitative estimations are possible. The IR spectroscopy is carried 
out by using Fourier transform technique.  
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Principle: 
  Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of the 
nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and electronic 
structure of the substance and with intra- and inter molecular interactions. 
Source   : Nernst Glower 
Beam splitter  :  It is made up of a transparent material. Thin  
films of  Silicondepositedon  Potassium bromide  
(KBr) Bromide (KBr) Detectors:  DeutratedTriGlycine Sulphate (DTGS). 
Scan Range  :  MIR 450to 4000 cm-1 
Resolution  :   4.0 cm-1 
Sample required : 50mg, solid or liquid 
Sampling Techniques: There are a variety of techniques for sample  
preparation physical form of the sample to be  
analyzed. 
Solid   : KBr or Nujol mull method. 
Liquid   : Csl / TIBr Cells 
Gas   : Gas cells 
 
Measurements Techniques: 
The procedure for recording the %T or %A is as follows: 
1. Air is first scanned for the reference and stored. The sample is then recorded 
and finally the ratio of the sample and reference data is computed to give 
required  % T  or % A at various frequencies. 
2. Study of substances with strong absorbance bands and weak absorbance bands 
aswell as possible. 
3. Small amount of samples are sufficient 
4. High resolution is obtained. 
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Procedure: 
  Typically,1.5 mg of protein, dissolved in the buffer used for its purification, were 
centrifuged in a 30 K Centric on micro concentrator (Amicon) at 3000_g at 4oC until a 
volume of approximately 40 Al. 
1. Then, 300 Al of 20 mM buffer, prepared in H20 or 2H20, pH or p2H 7.2, were 
added and the sample concentrated again. The p2H value corresponds to the pH 
meter reading + 0.4. The concentration and dilution procedure was repeated 
several times in order to completely replace the original buffer with the This 
buffer. 
2. The washings took 24 h, which is the time of contact of the protein with the 
2H20medium prior FT-IR analysis. In the last washing, the protein was 
concentrated to fine a volume of approximately 40 Al and used for the infrared 
measurements.The concentrated protein sample was placed in CaF2 windows and 
a 6 Am tin spacer or a 25 Am Teflon spacer for the experiments in H20 or 2H20, 
respectively. FT-IR spectra were recorded by means of a Perkin-Elmer -Spectrum-
1 FT-IR spectrometer using a deuteratedtriglycinesulfate detector. 
3. At least 24 h before, and during data acquisition, the spectrometer were 
continuously purged with dry air at a dew point of 40oC. Spectra of buffers and 
samples were acquired at 2 cm_1 resolution under the same scanning and 
temperature conditions. In the thermal denaturation experiments, the temperature 
was raised in 5oC steps from 20 to 95oC. 
4. Before spectrum acquisition, samples were maintained at the desired temperature 
for the time necessary for the stabilization of temperature inside the cell (6 
min).Spectra were collected and processed using the SPECTRUM software from 
Perkin-Elmer. Correct subtraction of H20 was judged to yield an approximately 
flat baseline at 1900-1400 cm_ 1, and subtraction of 2H20 was adjusted to the 
removal of the2H20 bending absorption close to 1220 cm_ 1 
 
KBr Method 
1. The sample is grounded using an agate mortar and pestle to give a very fine 
powder. 
2. The finely powder sample is then mixed with about 100mg dried KBr salt. 
3. The mixture is then pressed under hydraulic press using a die to yield a 
transparent disc and measure about 13mm diameter and 0.3mm in thickness. 
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Nujol Mull Method: 
1. The sample is ground using an agate mortar and pestle to give a very fine powder. 
2. A small amount is then mixed with nujol oil to give a paste and this paste is 
thenapplied between two sodium chloride plates. 
3. The plates are then placed in the instrument sample holder ready for scanning. 
 
Liquids: 
1. Viscous liquids can be smeared in the cell and directly measured. 
2. For dilute solutions, liquid cells and variable path length cells are employed. 
 
Applications: 
   Infrared spectrum is useful in identifying the functional groups like -OH, -CN, -
CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water and 
rubber samples can be analyzed.  
 
 
 
Fig. No. 3 Mechanism of FTIR analyzer 
 
Analytical Capabilities: 
1. Identifies chemical bond functional groups by the absorption of infrared radiation 
which excites vibrational modes in the bond. 
2. Especially capable of identifying the chemical bonds of organic materials  
3. Detects and identifies organic contaminants. 
4. Identifies water, phosphates, sulphates, nitrates, nitrites, and ammonium ions  
5. Detection limits vary greatly, but are sometimes <1013 bonds/cm3 or sometimes 
sub monolayer .Useful with solids, liquids, or gases. 
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Fig. No. 4  INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY(ICP-OES): 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
  Inductively coupled plasma optical emission spectrometry (ICP-OES) is an 
analytical technique used for the detection of trace metals. It is a type of emission 
spectroscopy that uses the inductively coupled plasma to produce excited atoms and ions 
that emit electromagnetic radiation at wavelengths characteristic of a particular element. 
The intensity of this emission is indicative of the concentration of the element within the 
sample. 
 
Mechanism: 
  The ICP-OES is composed of two parts:  ICP and the optical spectrometer. The 
ICP torch consists of 3 concentric quartz glass tubes. The output or “work” coil of the 
radiofrequency (RF) generator surrounds part of this quartz torch. Argon gas is typically 
used to create the plasma. 
  When the torch is turned on, an intense electromagnetic field is created within the 
coil by the high power radio frequency signal flowing in the coil. This RF signal is 
created by the RF generator which is, effectively, a high power radio transmitter driving 
the “workcoil” the same way a typical radio transmitter drives a transmitting antenna. The 
argon gas flowing through the torch is ignited with a Tesla unit that creates a brief 
discharge are through the argon flow to initiate the ionization process. Once the plasma is 
“ignited”, the Tesla unit is turned off. 
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  The argon gas is ionized in the intense electromagnetic field and flows in a 
particular rotationally symmetrical pattern towards the magnetic field of the RF coil. 
Stable, high temperature plasma of about 7000 K is then generated as the result of the 
inelastic collisions created between the neutral argon atoms and the charged particles.  A 
peristaltic pump delivers an aqueous or organic sample into a nebulizer where it is 
changed into mist and introduced directly inside the plasma flame. The sample 
immediately collides with the electrons and charged ions in the plasma and is itself 
broken down into charged ions. The various molecules break up into their respective 
atoms which then lose electrons and recombine repeatedly in the plasma, giving off 
radiation at the characteristic wavelengths of the elements involved. 
  Within the optical chamber(s), after the light is separated into its different 
wavelengths (colours), the light intensity is measured with a photomultiplier tube or tubes 
physically positioned to “view” the specific wavelength(s) for each element line involved, 
or, in more modern units, the separated colours fall upon an array of semiconductor photo 
detectors such as charge coupled devices (CCDs). In units using these detector arrays, the 
intensities of all wavelengths (within the system’s range) can be measured 
simultaneously, allowing the instrument to analyse for every element to which the unit is 
sensitive all at once. Thus, samples can be analysed very quickly. 
The intensity of each line is then compared to previously measured intensities ofknown 
concentrations of the elements and their concentrations are then computed by 
interpolation along the calibration lines. In addition, special software generally corrects 
for interferences caused by the presence of different elements within a given sample 
matrix.  
 
Applications : 
  ICP-OES is used in   the determination of metals, arsenic present in Traditional 
medicines, and trace elements bound to proteins. ICP-OES is widely used in minerals 
processing to provide the data on grades of various streams, for the construction of mass 
balances. 
  The author used it for elemental identification and quantitative compositional 
information of the KATTUVAI MATHIRAI. 
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4.2.5.4  X-RAY POWDER DIFFRACTION 
(XRD) INSTRUMENTATION 
 X-ray diffractometers consist of three basic elements: an X-ray tube, a 
sample holder and an X-ray detector. 
 
Fig.No. 5  Bruker’s X-ray Diffraction D8-Discover instrument. 
 X-rays are generated in a cathode ray tube by heating a filament to produce 
electrons, accelerating the electrons towards a target by applying a voltage and 
bombarding the target material with electrons. When electrons have sufficient energy to 
dislodge inner shell electrons of the target material, characteristic X-ray spectra are 
produced. These spectra consist of several components, the most common being Kα and 
Kβ. Kα consists in part of Kα1 and Kα2. Kα1 has a slightly shorter wavelength and twice the 
intensity of Kα2. The specific wavelengths are characteristic of the target material (Cu, Fe, 
Mo, Cr). Filtering, by foils or crystal monochrometers, is required to produce 
monochromatic X-rays needed for diffraction. Kα1 and Kα2 are sufficiently close in 
wavelength such that a weighted average of the two is used. Copper is the most common 
target material for single-crystal diffraction, with CuKα radiation = 1.5148A0. These X-
rays are collimated and directed onto the sample. As the sample and detector are rotated, 
the intensity of the reflected X-rays is recorded. When the geometry of the incident X-
rays impinging the sample satisfies the Bragg Equation, constructive interference occurs 
and a peak in intensity occurs. A detector records and processes this X-ray signal and 
converts the signal to a count rate which is then output to a device such as a printer or 
computer monitor. 
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The geometry of an X-ray diffractometer is such that the sample rotates in the path 
of the collimated X-ray beam at an angle θ while the X-ray detector is mounted on an arm 
to collect the diffracted X-rays and rotates at an angle of 2θ. The instrument used to 
maintain the angle and rotate the sample is termed a goniometer. For typical powder 
patterns, data is collected at 2θ from -50 to 700, angles that are present in the X-ray scan. 
 
Applications: 
 X-ray powder diffraction is most widely used for the identification of unknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is critical to studies in geology, environmental science, material science, 
engineering and biology. 
 
Other applications include: 
1. Characterization of crystalline materials 
2. Identification of the fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically. 
3. Determination of unit cell dimensions. 
4. Measurement of sample purity. 
 
With specialized techniques, XRD can be used to: 
1. Determine crystal structures using Rietveld refinement 
2. Determine of modal amounts of minerals (quantitative analysis) 
3. Make textural measurements such as the orientation of grains in a polycrystalline 
sample. 
 
Strengths and Limitations of X-ray Powder Diffraction: 
Strengths: 
1. Powerful and rapid (<20 min) technique for identification of an unknown 
minerals. 
2. In most cases, it provides an unambiguous mineral determination. 
3. Minimal sample preparation is required. 
4. XRD units are widely available. 
5. Data interpretation is relatively straight forward. 
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Limitations: 
1. Homogenous and single phase material is best for identification of an unknown 
2. Must have access to a standard reference file of inorganic compounds (d-spacings, 
hkls) 
3. Requires tenths of a gram of material which must be ground into a powder. 
4. Foe mixed materials, detection limit is -2% of sample. 
5. For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated. 
6. Peak overlay may occur and worsens for high angle ‘reflections’. 
 
User’s Guide-Sample Collection and Preparation: 
Determination of an unknown requires: the material, an instrument for grinding 
and a sample holder. 
1. Obtain a few tenths of a gram (or more) of the material, as pure as possible. 
2. Grind the sample to a fine powder, typically in a fluid to minimize inducing extra 
strain (surface energy) that can offset peak positions, and to randomize 
orientation. 
a. Powder less than -10 µm (or 200-mesh) in size is preferred. 
3. Place into a sample holder or onto the sample surface. 
a. Packing of the fine powder into a sample holder. Smear uniformly onto a 
glass slide, assuring a flat upper surface. 
4. Pack into a sample container 
5. Sprinkle on double sticky tape 
a. Typically the substance is amorphous to avoid interference 
6. Care must be taken to create a flat upper surface and to achieve a random 
distribution of lattice orientations unless creating an oriented smear. 
7. For unit cell determinations, a small amount of a standard with known peak 
positions (that do not interfere with the sample) can be added and used to correct 
peak positions. 
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Data Collection, Results and Presentation: 
Data collection: 
  The intensity of diffracted X-rays is continuously recorded as the sample and 
detector rotate through their respective angles. A peak in intensity occurs when the 
mineral contains lattice planes with d-spacings appropriate to diffract X-rays at that value 
of θ. Although each peak consists of two separate reflections (Kα1 and Kα2), at small 
values of 2θ the peak locations overlap with Kα2 appearing as a hump on the side of Kα1. 
Greater separation occurs at higher values of θ. Typically these combined peaks are 
treated as one. The 2λ position of the diffraction peak is typically measured as the center 
of the peak at 80% peak height. 
Data reduction: 
  Results are commonly presented as peak positions at 2θ and X-ray counts 
(intensity) in the form of a table or an x-y plot (shown above). Intensity (I) is either 
reported as peak height intensity, that intensity above background, or as integrated 
intensity, the area under the peak. The relative intensity is recorded as the ratio of the 
peak intensity to that of the most intense peak (relative intensity =I/I1 x 100). 
The d-spacing of each peak is then obtained by solution of the Bragg equation for 
the appropriate value of λ. Once all d-spacings have been determined, automated 
search/match routines compare the ds of the unknown to those of known materials. 
Because each mineral has a unique set of d-spacings, matching these d-spacings provides 
an identification of the unknown sample. A systematic procedure is used by ordering the 
d-spacings in terms of their intensity beginning with the most intense peak. Files of d-
spacings for hundreds of thousands of inorganic compounds are available from the 
International Centre for Diffraction Data as the Powder Diffraction File (PDF). Many 
other sites contain d-spacings of minerals such as the American Mineralogist Crystal 
Structure Database. Commonly this information is an integral portion of the software that 
comes with the instrumentation. 
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4.3. TOXICOLOGICAL STUDIES  
4.3.1. ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF KATTUVAI  MATHIRAI  
OBJECTIVES 
  The aim of this Study is to evaluate the toxicity of the test substance Kattuvai  
Mathirai , when administered orally to Female Wister Rats with different doses, so as to 
provide a rational base for the evaluation of the toxicological risk to man and indicate 
potential target organs. 
 
Guidelines followed: 
  (a)  OECD Guidelines No. 423, 
 
Study Design and Controls: 
1) Female Wister Rats in controlled age and body weight were selected. 
2) Kattuvai  Mathirai  was administered at 5 mg/kg, 50 mg/kg,  300 mg/kg,1000  
mg/kg, 2000  mg/kg,  body weight as  (Water) as suspension along with blank. 
3) The results were recorded on day 0, with single oral dosing period of 14 days.  
 
EXPERIMENTAL PROCEDURE 
1. ANIMALS  
Supply 
        A total of 15 Female Wister Rats with an approximate age of 6 weeks and purchased 
from Central Animal House, Arulmigu Kalasalingam college of pharmacy, krishnankoil. 
On their arrival a sample of animals was chosen at random and weighed to ensure 
compliance with the age requested. The mean weights of Female Wister Rats were 100-
150 g respectively.  The animals were housed in metabolic cages (55 x 32.7 x 19 cm), 
with sawdust litter, in such a way that each cage contained a maximum of 3 animals of 
the same sex. 
  All animals underwent a period of 20 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this period, the 
animals were inspected by a veterinary surgeon to ensure that they fulfilled the health 
requirements necessary for initiation of the Study. 
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Housing 
  The Female Wister Rats were housed in metabolic cages (55 x 32.7 x 19 cm), 
placed on racks. From the week before initiation of the treatment, each cage contained a 
maximum of 3 rats of the same sex and treatment group. 
  Each cage was identified by a card, color coded according to the dose level. This 
card stated the cage number, number and sex of the animals it contained, Study number, 
test substance code, administration route, dose level and Study Director's name, date of 
the arrival of the animals and initiation of treatment. 
  The temperature and relative humidity were continuously monitored. Lighting was 
controlled to supply 12 hours of light (7:00 to 19:00 hours) and 12 hours of dark for each 
24-hour period. 
  The cages corresponding to each experimental group were distributed on racks in 
such a manner that external factors, such as environmental conditions, were balanced as 
far as possible. 
2. DIET 
     All the rats had free access to a pelleted rat diet. The diet was analyzed by the   
manufacturer to check its composition and to detect possible contaminants. 
Water 
  The water was offered ad libitum in bottles.  
 
3. ADMINISTRATION ROUTE AND PROCEDURE 
          The test substance was administered orally. The Female Wister Rats belonging to 
the control group were treated with the vehicle (Water) at the same administration volume 
as the rest of the treatment groups. 
Table – 2  Numbering and Identification 
  The animals were marked on body with picric acid solution prepared in water. The 
marking within the cage was as below. 
Table – 2  Numbering and Identification 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
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 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage label and body marking on the animals 
 
Cage No Group No Animal Marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
 
Doses 
  The doses for the study were selected based on literature search and range finding 
study. Following the period of fasting, the animals were weighed and then drug was 
administered orally as single dose using a needle fitted onto a disposable syringe of 
approximate size at the following different doses. 
 
GROUP DOSE 
Group-I 5  mg/kg 
Group-II 50  mg/kg 
Group-III 300 mg/kg 
Group-IV 1000  mg/kg 
Group-V 2000 mg/kg 
 
  The test item was administered as single dose. After single dose administration 
period, all animals were observed for day 14. 
 
Dose Preparation 
  Kattuvai  Mathirai  was added in distilled water and completely dissolved to form 
oral for administration. The dose was prepared of a required concentration before dosing 
by dissolving, in distilled water. It was mixed well. The preparation for different doses 
was vary in concentrations to allow a constant dosage volume. 
 
  
  
   104 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
Administration 
  The test item was administered orally to each Female Wister rats as single dose 
using a needle fitted onto a disposable syringe of appropriate size at the following 
different doses. The concentration was adjusted according to its body weight. The volume 
was not exceeding 10 ml/kg bodyweight. Variability in test volume was minimized by 
adjusting the concentration to ensure a constant volume at all dose levels. 
 
Observation period 
  All animals were observed for any abnormal clinical signs and behavioral 
changes. The appearance, change and disappearance of these clinical signs, if any, were 
recorded for approximately 1.0, 3.0 and 4.0 hours post-dose on day of dosing and once 
daily thereafter for14 days. Animals in pain or showing severe signs of distress were 
humanely killed. The cageside observation was included changes in skin, fur, eyes and 
mucous membranes, occurrence of secretions and excretions. Autonomic activity like 
lacrimation,  piloerection, pupil size and unusual respiratory pattern, changes in gait, 
posture, response to handling, presence of clonic or tonic movements, stereotypes like 
excessive grooming and repetitive circling or bizarre behavior like self-mutilation, 
walking backwards etc were observed. At the 14th day, sensory reactivity to stimuli of 
different types (e.g. auditory, visual and proprioceptive stimuli) was conducted. Auditory 
stimuli responses were measured by clicker sound from approximately 30 cm to the rats; 
visual stimuli response were measured with the help of shining pen light in the eye of rats 
and placing a blunt object near to the eye of rats. Response to proprioceptive stimuli was 
measured by placing anterior/dorsal surface of animals paw to the table edge. The 
responses of reactions for these three exercises were normal in animals belonging to both 
the controls as well as drug treatment dose groups. 
 
Mortality and Morbidity 
  All animals were observed daily once for mortality and morbidity at 
approximately 1.0, 3.0 and 4.0 hours post dose on day of dosing and twice daily (morning 
and afternoon) thereafter for 14 days. 
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4.3.2. SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF KATTUVAI  MATHIRAI     
                              
Objective 
  The objective of this ‘Sub-Acute Toxicity Study of  Kattuvai  Mathirai on 
Wister Rats’ was to assess the toxicological profile of the test item when treated as a 
single dose. Animals should be observed for 28 days after the drug administration. This 
study provides information on the possible health hazards likely to arise from exposure 
over a relatively limited period of time.  
 
Test Guideline Followed 
      OECD 407 Method - Sub-Acute Toxic Class Method (Repeated Dose 28-Day Oral 
Toxicity Study in Rodents) 
 
Test Item Detail 
  Kattuvai  Mathirai 
 
Test System Detail 
  The study was conducted on 5 male 5 female Wister rats. These   animals were 
selected because of the recommended rodent species for oral studies as per followed 
guideline and availability of Animals 8-12 weeks old male and female rats were selected 
after physical and behavioral examination. The body weight range was fallen within ± 
20% of the mean body weight at the time of Randomization and grouping. The rats were 
housed in standard laboratory condition in Polypropylene cages, provided with food and 
water adlibitum in the Animal at Central Animal House, Arulmigu Kalasalingam College 
of Pharmacy, Krishnankoil. The experimental protocol was approved by Institutional 
Animal Ethical Committee as per the guidance of Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and 
Forest, government of India. 
 
Acclimatization 
   The animals were selected after veterinary examination by the veterinarian. All 
the selected animals were kept under acclimatization for a week. 
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Randomization & grouping 
  One day before the initiation of treatment (days 0- last day of acclimatization), the 
selected animals were randomly grouped into three different groups containing minimum 
5 male and 5 female animals per group.  
 
The animals were marked on body with picric acid solution prepared in water. The 
marking within the cage was as below.   
Table – 3 Numbering and Identification 
   
 
 The group  no., cage no., sex of the animal and animal no. were identified  as 
indicated below  using cage  label and body marking on the animals: 
 
Case 
No 
Group No Animal Marking Sex 
1 CONTROL 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
2 
Low dose of  KATTUVAI  
MATHIRAI 300mg/kg 
H,B,T,HB,NM 
H,B,T,HB, NM 
Male 
Female 
3 
Middle dose of KATTUVAI  
MATHIRAI 600mg/kg 
H,B,T,HB,NM                   
H,B,T,HB, NM 
Male 
Female 
4 
High dose of  KATTUVAI  
MATHIRAI 900 mg/kg 
H,B,T,HB,NM 
H,B,T,HB ,NM 
Male 
Female 
  
Case 
No 
Group No Animal Marking 
1 CONTROL 
H,B,T,HB,NM   (Male)               
H,B,T,HB, NM (Female 
2 
Low dose of  KATTUVAI  
MATHIRAI 300mg/kg 
H,B,T,HB,NM  (Male)                  
H,B,T,HB, NM (Female) 
3 
Middle dose of KATTUVAI  
MATHIRAI 600mg/kg 
H,B,T,HB,NM  (Male)                  
H,B,T,HB, NM (Female) 
4 
High dose of  KATTUVAI  
MATHIRAI 900 mg/kg 
H,B,T,HB,NM  (Male)           
H,B,T,HB ,NM (Female) 
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Husbandry 
Housing 
   The Wister rats were housed in standard polypropylene cages with stainless steel 
top grill. Paddy husk was used as bedding. The paddy husk was changed at least twice in 
a week. From the week before   initiation of the treatment, each cage contained a 
maximum of  10 rats of the same sex and treatment group. 
Environmental conditions 
  The animals were kept in a clean environment with 12 hour light and 12 hour dark 
cycles. The air was conditioned at 22±30C and the relative humidity was maintained 
between 30-70% with 100% exhaust facility. The cages corresponding to each 
experimental group were distributed on racks in such a manner that external factors, such 
as environmental conditions, were balanced as far as possible. 
Feed & feeding schedule 
  Feed was provided adlibitum throughout the study period, except over night 
fasting (18-20 hours) prior to dose administration. After the substance has been 
administered, food was with held for a further 3-4 hours. 
Water 
  The water was offered adlibitum in bottles. There was periodically analyzed to 
detect the presence of possible contaminants 
Doses 
  The doses for the study were selected based on literature search and range finding 
study. Following the period of fasting, the animals were weighed and then extract was 
administered orally as single dose using a needle fitted on to a disposable syringe of 
approximate size at the following different doses. 
 
Test Group 
Dose to Animals 
(mg/kg body –weight / day Number of Animals 
Group – I CONTROL 10 ( 5 Male  and 5 Female) 
Group – II Low dose of  KM  300mg/kg 10 ( 5 Male  and 5 Female) 
Group – III Middle dose of KM 600mg/kg 10 ( 5 Male  and 5 Female) 
Group - IV High dose of  KM  900 mg/kg 10 ( 5 Male  and 5 Female) 
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  The test item was administered as single dose. After single dose administration 
period, all animals were observed for 28 days. 
Dose Preparation 
  Kattuvai  Mathirai was added in distilled water and completely dissolved to for 
oral for administration. The dose was prepared of a required concentration before dosing 
by dissolving Kattuvai  Mathirai in distilled water. It was mixed well. The preparation for 
different doses was vary in concentrations to allow a constant dosage volume. 
Administration 
  The test item was administered orally to each   rat as single dose using a needle 
fitted on to a disposable syringe of appropriate size at the following different doses. The 
concentration was adjusted according to its body weight. The volume was not exceeding 
10 ml/kg body weight. Variability in test volume was minimized by adjusting the 
concentration to ensure a constant volume at all dose levels. 
 
OBSERVATIONS  
  These observations were also performed on week-ends. The observations included   
but were not limited to changes in skin and fur, in the eyes and mucous membranes, in the 
respiratory, circulatory, central nervous and autonomous systems, somatomotor activity 
and behavior. 
 
Clinical signs of toxicity  
          All the rats were observed at least twice daily with the purpose of recording any 
symptoms of ill- health or behavioral changes. Clinical signs of toxicity daily for 28 days. 
 
Food intake  
  Prior to the beginning of treatment, and daily, the food intake of each cage was 
recorded for period of 28 days and the mean weekly intake per rats was calculated. 
 
Water intake 
  Water intake was checked by visual observation during the Study. In addition, the 
water consumption in each cage was measured daily for a period of 28 days. 
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Bodyweight: 
  The body weight of each rat was recorded one week before the start of treatment, 
and during the course of the treatment on the day of initial, 3rd, 7th, 10th, 14th, 17th, 
20th, 24th and 28th days (day of sacrifice). The mean weights for the different groups and 
sexes were calculated from the individual weights. 
 
Blood Collection  
  Blood was collected through retro-orbital sinus from all the animals of different 
groups on 28th day. The blood was collected in tubes containing Heparin/EDTA as an 
anticoagulant. Animals were fasted over night prior to the blood collection. 
 
LABORATORY STUDIES  
    During the 4th week of treatment, samples of blood were withdrawn from the 
orbital sinus of 5 males from each group, under light ether anesthesia after fasting for 16 
hours. The blood samples are used to evaluate Hematological   parameters like RBC, 
WBC, and PLATELETS etc….. The collected blood samples also centrifuged 10000 rpm 
in 10 minutes to separate the serum. The separated serum used to evaluate biochemical 
parameters like SGOT, SGPT, ALP and BILIRUBIN ect……... 
 
Hematology  
The following hematological parameters were analysed using Autoanalyser  
Hb  :  Haemoglobin (g %)  
PCV   :  Packed Cell Volume 
WBC  :  White Blood Corpuscles (x103/cmm)  
RBC  :  Red Blood Corpuscles (x106/cmm)  
Blood Platelet count (x103/cmm)  
Differential WBC count:  
N  :  Neutrophils (%)  
L  :  Lymphocytes (%)  
M  :  Monocytes (%)  
E  :  Eosinophils (%)  
RDW  :  Red Cell Distribution Width. 
MPV  :  Mean Platelet Volume 
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Clinical Biochemistry:  
  The following clinical Bio parameters were analysed using Auto analyser  
Total serum protein (g/dl)  
ALT/SGPT  :  Alanine amino transferase (U/L)  
AST/SGOT  :  Aspartate amino transferase (U/L)  
ALP    :  Alkaline serum phosphatase (U/L)  
CHL    :  Cholesterol (mg/dL)  
HDL    :  High density lipoprotein 
TG    :  Triglyceride 
 
TERMINAL STUDIES  
Sacrifice and macroscopic examination 
  On completion of the 4 weeks of treatment, 18 Wister rats were sacrificed by ether 
inhalation. A full autopsy was performed on all animals which included examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents both in situ and after evisceration. As the number of animals exceeded the 
number that could be sacrificed in one day, the autopsies were carried out over three 
consecutive days at the end of the treatment period.  
 
Organ weights: 
            After the macroscopic examination the following organs were weighed after 
separating the superficial fat: Brain, Heart, Spleen Kidneys, Testes, Liver, Lungs, 
pancreas and stomach.   
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4.4.PHARMACOLOGICAL STUDY 
 
4.4.1. ANTI-DIARRHOEAL ACTIVITY 
 
EFFECT OF KATTUVAI  MATHIRAI ON CASTOR OIL – INDUCED SMALL 
INTESTINAL TRANSIT IN RATS 
 
 The experiment was performed according to the method of Venkatesan et al. 
(2005). Rats were fasted 48 h, and water was given ad libitum. The water was withdrawn 
1 h before starting the experiment. Male Wister rats were given Normal saline (orally), 
atropine sulfate (intraperitoneally, i.p) and test compounds (orally). Thirty minutes later, 
they were orally fed with 1 ml of 3% deactivated charcoal (in 0.5% CMC). Thirty 
minutes after the deactivated charcoal feeding, the rats were sacrificed with 
intraperitoneal injection of pentobarbital sodium (50 mg/kg) and the gastrointestinal tract 
was removed. Total length of the small intestine (pylorus to caecum), and the distance of 
the deactivated charcoal movement were measured. The small intestine transit was 
calculated and expressed as percentage of the deactivated charcoal movement. 
 
 
Animal Grouping 
Group I -  Control (Distilled Water) 
Group II -  Castor oil +Charcoal 
Group III -  Castor Oil +Atropine  (3mg/kg) 
Group IV -  Castor oil (1ml p.o) + Kattuvai Mathirai  
(100 mg/kg ) 
Group V -  Castor oil  (1ml p.o) +  Kattuvai Mathirai  
(200 mg/kg ) 
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4.4.2. ANTI-PYRETIC ACTIVITY 
EFFECT OF KATTUVAI MATHIRAI ON BREWER’S YEAST INDUCED 
PYREXIA IN RATS 
MATERIALS AND METHODS 
Experimental Animals  
Wistar albino rats of either sex weighing about 150-200g were employed for this study. 
They were procured from Kalasalingam college of Pharmacy, srivilliputhurand 
maintained on the suitable nutritional and environmental condition throughout the 
experiment. They were housed in polypropylene cages with paddy house bedding under 
standard laboratory condition for an acclimatization periods of 7 days prior to performing 
the experiment. 
Experimental Design . 
Protocol 
Body weights of the animals were recorded and they were randomly divided into 5 groups 
of 6 animals each as follows: 
Group I  :  animals served as control  
Group II  :  animals were treated with yeast via subcutaneous   injection (10ml/kg).  
Group III  :  animals were administered with yeast (10 ml/kg) and the standard drug  
paracetamol (150mg/kg b.w.), orally  
Group IV  :  animals were administered with yeast (10ml/kg,) and with KM 
(100mg/kg b.w.), orally.  
Group V  :  animals were administered with yeast (10ml/kg,) and with 
KM(200mg/kg b.w.), orally.   
Yeast induced pyrexia  
Pyrexia was induced by subcutaneous injection of 20 % w/v of brewer’s yeast (10ml/kg) 
in distilled water. Basal rectal temperature was measured before the injection of yeast, by 
inserting digital clinical thermometer to a depth of 2 cm into the rectum.  
The rise in rectal temperature was recorded 19 h after yeast injection. Paracetamol 
150mg/kg body weight was used as the standard antipyretic drug. Rectal temperature of 
animals was noted at regular intervals following the respective treatments.The 
temperature was measured at 1st, 2nd, and 3rd hour after drug administration. 
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Experimental Doses calculated as per the standard procedures are: 
 
S.No Groups 
Dose/kg 
weight 
Dose/200 gms 
weight 
Volume of 
administration 
1. Vehicle Control - - 0.5ml 
2. 
Therapeutic 
Dose 
23mg 4.6mg 0.5ml 
3. Average Dose 115mg 23mg 0.5ml 
4. High Dose 230 mg 46mg 0.5ml 
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4.4.3.ANTI SPASMODIC ACTIVITY 
EFFECT OF KATTUVAI  MATHIRAI ON EXCISED GUINEA PIG ILEUM 
ISOLATION OF GUINEA PIG ILEUM (IN-VITRO) 
 Guinea pig were anesthetized and sacrificed by cervical displacement followed by 
exsanguinations.  The ileum was dissected out, immersed in tyrode’s solution and cleaned 
off the mesentery.  Respective segments of 2-3 cm long were mounted in a 25ml tissue 
organ bath, filled with a mixture of 95% O2 and 5% Co2 and maintained at 37°C.  The 
composition of Tyrode’s solution (in mM for 1 lit) was 9 mg KCl, 0.1mg NaCl, 0.1mg 
NaHCo3, 0.42mg NaH2PO4, 0.6 mg Glucose and pH value was 7.4. 
ANTI-SPASMODIC ACTIVITY ASSAY PROCEDURE: 
1. Firstly concentration dependent responses of acetylcholine awere recorded (with 
dose of 0.1ml, 0.2ml, 0.4ml, 0.8ml, 1.6ml, 3.2ml) using Sherrington’s recording 
drum with a frontal writing level.  Contact time of 60 sec, and base line of 30 sec 
time cycle were opted for proper recording of the responses in presence of plane 
Tyrode’s solution as stock – I solution. 
2. Then same concentration dependent responses of acetylcholine (Ach) using same 
procedure for a mixture of Tyrode’s solution+ KM (with a concentration of 
1mg/ml) as a stock-II solution were recorded. 
3. Lastly the same concentration dependent responses of Ach for a mixture of 
Tyrode’s solution+ Atropine (as a standard antispasmodic agent) as a stock-III 
solution were recorded. 
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5. MICROBIOLOGICAL ANALYSIS 
ANTI - MICROBIAL STUDIES 
Aim 
   To study the Anti-microbial action of “Kattuvai  Mathirai” done by “Agar well 
diffusion method” – Kirby – bauyermethod. 
 
Components of Muller Hinton agar medium 
         Beef extract   -  300gms/lit 
         Agar    -  17 gms/lit 
         Starch    -  1.5 gms/lit 
         Casein Hydrolysate  -  17.5 gms/lit 
         Distilled water  -  1000 ml 
         PH   -  7.6 
 
Procedure: 
  The method of antibacterial activity study is UPS Diffusion Method. Antibiotic 
discs are prepared with known concentration of antibiotic are placed on agar plates that 
has been inoculated with the known pathogenic micro organism. The antibiotic diffuses 
through the agar producing an antibiotic concentration, gradient antimicrobial 
susceptibility is proportional to the diameter of the inhibitory zone around the disc. If the 
microorganism which grows up to the edge of the disc are resistant to the antimicrobial 
agent. The recommended medium in this method is Muller Hinton Agar, its PH should be 
between 7.2-7.6 and should be poured to uniform thickness of 4mm in the petri plate 
(25ml). 
 
Methodology: 
  Muller Hinton Agar plates are prepared and Pseudomonas, Staphylococcus 
aureus,  Escherichia coli, is inoculated separately. 
  The prepared disc of Kattuvai  Mathirai are placed over the incubated plate using 
sterile forceps and incubated for 24 hours at 37 degree celcius. The plates after 24 hours 
incubation are observed for the zone of inhibition. 
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6. RESULTS AND DISCUSSION 
 STANDARDISATION OF KATTUVAI MATHIRAI  
  The test drug Kattuvai Mathirai had been subjected to various studies to establish 
the works of Siddhar`s to be true. Literary collections, physico-chemical and elemental 
analysis, pharmacological study, toxicological study and antimicrobial study are done to 
prove the activity of Kattuvai Mathirai as an anti-diarrhoeal, anti-pyretic and anti-
spasmodic  activities. 
Table – 4 Physico Chemical Standardisation. 
SL. NO. PARA METER RESULTS 
1. Organo leptic characters  
a. Color 
b. Odour 
c. taste 
d. Sense of touch 
e. Appearance 
 
Brown 
Pleasant odour 
Astringent,  bitter 
Hard 
Round 
1. Physico chemical standard 
a. Loss on drying at 70°C 
b. Ash  
i. Total ash 
            ii. Acid insoluble ash 
            iii. Water soluble  
 
c. Extractive value 
i. Ethanol soluble extractive 
ii. Water soluble extractive 
d. pH value (1% solution) 
             
 
7.30 % 
 
8.50% 
0.95 % 
7.75 % 
 
8.20 % 
9.20 % 
7.540 
 
Interpretation: 
  The physical parameters like brown in colour, plesant odour, hard to touch, 
astringent and  bitter in taste, round in appearance revealed that Kattuvai Mathirai is 
having the  PH 7.540 slightly alkaline.  
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Determination of loss on drying normal: 
  The loss on drying test is designed to measure the amount of volatile matters in a 
sample when the sample is dried under specified conditions moisture is one of the major 
factors.  Responsible for the deterioration of the drugs and formulations low moisture 
content is always desirable for higher  stability of days. 
  The percentage of loss on drying was within acceptable range to thus implying 
that the formulation can be stored for a long period and would not easily be attacked by 
microbes. 
 
Total Ash: 
  Ash values are helpful in determining the quality and purity of crude drugs.  In 
this trial drug KATTUVAI MATHIRAI (The minerals that present in the trial drug are 
calcium, chloride, sulphate) the salts, Ca+, Cl-, Sulphate are not harmful one. In this trial 
drug KATTUVAI MATHIRAI is used as a condensation  from water extraction . So only 
water soluble trace elements present here in a very few trace levels. The total ash value of 
Kattuvai Mathirai was 8.50%. 
 
Acid insoluble Ash: 
  Acid insoluble ash values represents detecting the presence of silica and oxalate in 
a drugs. In my drug the silica and oxalate that is the acid insoluble ash is very low on 
0.95%. So the drug has high quality. 
 
Water soluble ash: 
  Water soluble ash also indicate the purity of the drug water soluble ash higher 
than acid insoluble ash represents good quality of the drug which is KATTUVAI 
MATHIRAI is 7.75%. So water soluble ash is higher than acid insoluble ash. 
 
b)Water soluble extractive 
               Proceed as directed for the determination of Alcohol-soluble extractive , using 
chloroform water instead of ethanol. Water soluble extractive of Kattuvai Mathirai is 
9.20%. 
 
c)Alcohol soluble extractive 
                Macerate 5g of the air dried drug, coarsely powdered, with 100ml of alcohol of 
the specified strength in a closed flask for 24 hrs, shaking frequently during six hours and 
allowing to stand for eighteen hours. Filter rapidly, taking precautions against loss of 
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solvent, evaporate 25 ml of the filtrate to dryness in a tared flat bottomed shallow dish, 
and dry at 105o,to constant weight and weigh. Calculate the percentage of alcohol-soluble 
extractive with reference to the air-dried drug. Alcohol soluble extractive of Kattuvai 
Mathirai is 8.20% 
Microbial Limit Tests 
Table 1: Results of Microbial Contamination Test 
S.No. Test Particulars 
Colony Counts 
(CFU/ g) 
Limits Value 
(CFU/g) 
1. Total  Viable Aerobic Bacterial Count 13.5 x102 1x105 
2. Total  Viable Fungal Count 3.5 x102 1x103 
 
Table 2. Results of Specific Pathogens Test 
S.No. Test for Specified Pathogens 
Colony Counts 
(CFU/ g) 
Limits Value 
(CFU/g) 
1. Salmonella sp.  No growth - 
2. Staphylococcus aureus No growth - 
3. Escherichia coli No growth - 
4. Pseudomonas aeruginosa No growth - 
 
Interpretation 
  The total bacterial count and the total fungal count of the drug were found to be 
within the WHO prescribed limits which indicate that the drug is free from microbial 
contamination. The other pathogens like Escherichia coli, Salmonella sps, Pseudomonas 
aeruginosa and Staphylococcus aureus were found to be completely absent in the drugs.   
 
Disintegration: 
  The disintegration of test sample under the  specifications not more than 15 
minutes. In the present analysis the KATTUVAI MATHIRAI  disintegration on only 10m 
50 sec. 
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BIO CHEMICAL ANALYSIS 
Table – 5  Results of Preliminary test for basic and acidic radicals 
S.NO EXPERIMENT INFERENCE 
1. Test for Calcium Absent 
2. Test for Sulphate Present 
3. Test for Chloride Present 
4. Test for Carbonate Absent 
5. Test for Starch Present 
6. Test for Ferric Iron Absent 
7. Test for Ferrous Iron Present 
8. Test for Phosphate Absent 
9. Test for Albumin Absent 
10. Test for Tannic Acid Present 
11. Test for Unsaturated Compounds Present 
12. Test for Reducing Sugar Present 
13. Test for Amino Acid Present 
14. Test for Zinc Absent 
 
INTERPRETATION: 
   The biochemical analysis  of Kattuvai Mathirai contains the following chemical 
constituents, Sulphate, Chloride, Starch, Ferrous iron,  Unsaturated compound, Reducing 
sugar, Tannic acid and Amino acid. 
 
1. Sulphate: 
  Sulphur is a very versatile molecule, because it can exit in several distinct 
oxidative states, ranging from +6 in sulphate radicle – 2 in Hydrogen sulfide. 
  Sulfur is a healing mineral and plays a role in metabolism. Sulfur is present in 
insulin. 
 2.Chloride : 
  Chloride regulate the acid base balance of the body fluids, by maintaining the 
osmotic pressure of the body fluids. In severe diarrhoea, vomiting, large amount of water 
and electrolytes are lost from body. The dehydration has to be treated by administering 
water and these electrolytes. 
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3.Starch:  
  Starch functions much like dietary fibre. They provide nutrition for the beneficial 
bacteria in the colon, keeping them thriving and health.  Dietary fibre in starch reduces 
effects of haemorrhoids, diverticulosis & controls blood pressure. 
4.Ferrous Iron : 
  Iron is easily soluble and readily absorbed from intestine and involved. 
5.Tannic Acid: 
  Tannins are water soluble polyphenols that are present in many plant 
foods.Tannins in fruit have natural defence mechanism against microbial infection.Helps 
in healing of wounds and inflammation of mucous membrane. They restore the Anti-
Oxidant status of the organs to almost normal levels. Increases the cellular Anti-Oxidant 
enzymes.  
6. Unsaturated compound: 
  Monounsaturated and polyunsaturated fats can replace saturated fat in the diet, 
trans unsaturated fats should not. Replacing saturated fats with unsaturated fats helps to 
lower levels of total cholesterol and LDL cholesterol in the blood.  
7. Reducing sugar 
  Reducing sugar is essential for mental function and good physical activity. 
8. Amino Acid : 
1. Amino acids are involved in protein synthesis. 
2. Amino acid nourishes smooth muscles  of GIT 
3. The body can also use aminoacid for energy when lack of carbohydrates and fats. 
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PHYTOCHEMICAL STUDY OF KATTUVAI MATHIRAI 
The Kattuvai Mathirai was subjected to qualitative chemical investigation Details 
of the various tests performed for the presence of phytoconstituents is shown in Table 6.  
Table – 6  Phytochemical tests for KATTUVAI MATHIRAI 
Tests 
 
KATTUVAI 
MATHIRAI 
Alkaloids  
Mayer’s test  +ve  
Dragendroff’s test  +ve 
Hager’s test  -ve  
Carbohydrates and glycosides  
Molisch test  +ve  
Legal’s test  -ve  
Borntrager’s test for anthraquinones  -ve  
Phytosterols  
Liebermann-Burchard test  -ve  
Salkowski test  -ve  
Flavanoids  
Shinoda test  
Magnesium turnings and hydrochloric acid  
(Presence of red color)  
-ve  
Fluorescence test  -ve  
Tannins  
Ferric chloride test  -ve  
Potassium dichromate test  -ve  
Lead acetate test  +ve  
Proteins  
Millon’s test  -ve  
Biuret test  -ve  
Ninhydrin test  +ve  
Fixed oils and fats  
Spot test  -ve  
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Saponification test  +ve  
Lignin  
Phloroglucinol test  +ve  
Saponins  
Frothing test  -ve  
(+ve) indicates the presence of phytochemical, (-ve) indicates the absence of 
phytochemical. 
INTERPRETATION: 
Alkaloids-decreased gastric acid secretion and inhibit the gastric motility 
Tannins-Tannins react with tissue promote tissue proteins. 
This study revealed the presence of active phytochemicals in Kattuvai Mathirai such 
as alkaloids, carbohydrates, glycosides, tannins, lignins. 
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INSTRUMENTAL ANALYSIS 
SCANNING ELECTRON MICROSCOPE (SEM) 
 
SEM -20000 Magnification 
 
SEM -30000 Magnification 
Figure – 6  Showing SEM Results of Trial Drug (KATTUVAI MATHIRAI ) 
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INTERPRETATION : 
 
  The morphology of the Kattuvai Mathirai samples can be determined by 
Environmental SEM (FEI Quanta). A representative portion of each sample must be  
sprinkled onto a double side carbon tape and mounted on aluminium stubs, in order to get 
a higher quality secondary electron image for SEM examination. The SEM photographs 
revealed that particles were spherical in shapes and sizes were in the range from 1µm to 
5µm.Although the particle sizes of different batches showed similarity, it seems that these 
particles were aggregates of much smaller particles.  
  When dispersed in an aqueous medium, these preparations form a negatively 
charged hydrophobic particle suspension. This hydrophobicity gave these particles a 
tendency to aggregate together to form larger particles. Kattuvai Mathirai exhibited larger 
sizes and agglomeration of the particles. Therefore, the comparatively larger size may be 
due to the agglomeration of the particles by repeated cycles of calcinations involved in 
preparation. SEM analysis of the Kattuvai Mathirai shows most of the particles present in 
the sample are nano size, average particle size is  2 - 1µm. 
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FOURIER TRANSFORM-INFRARED SPECTROSCOPY( FTIR) 
 
  Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in absorption 
spectra that provide information about the functional group and molecular structure of a 
material IR relates with the sample and the bonds among atoms in the molecule stretch 
and bend, absorbing infrared energy and creating the infrared spectrum. It is of two kinds 
of bending and stretching. 
  FT-IR is a very useful tool in the recognition of the functional groups of bio 
molecules, thus aiding in their structural elucidation, so confirming the presence of active 
molecules responsible for the therapeutic activity of Siddha drugs. The results of Table 
no: 7 and Fig no:7 shows the presence of functional group and inorganic compounds of 
Kattuvai Mathirai  
 
 
                      Figure - 7  Showing FTIR Image of KATTUVAI MATHIRAI  
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Table – 7  Interpretation of FTIR Spectrum 
 
S.No Frequency Bond Functional Group 
1. 2926.01 C-H Stretch Alkane 
2. 2854.65 C-H Stretch Alkane 
3. 1745.58 C= O Ester 
4. 1656.85 C=N Stretch Oxime 
5. 1544.98 N-O Stretch Nitro compound 
6. 1460.11 CH3 Bend Alkane 
7. 1321.24 C-N Stretch Aromatic amine 
8. 1242.16 C-N Stretch Amine 
9. 1161.15 C-O Stretch Tertiary alcohol 
10. 1099.43 C-O Stretch Secondary alcohol 
11. 779.24 C-Cl Stretch Halo - compound 
12. 721.38 C=C Bending Alkane 
 
INTERPRETATION: 
1. It confirms that Kattuvai Mathirai constitutes Alkanes, Ester, Oxime, Nitro 
compounds, Amine, Tertiary alcohol, Secondary alcohol, Halo-compound as 
functional  groups.  
Alkenes :  
  When red blood cells reach the end of their lifetime(about 3months)they lise and 
released red coloured haemoglobin,the molecule that actually transports oxygen in the 
blood.The heme portion of hemoglobin is metabolized into orange coloured bilirubin.A 
very small amount of bilirubin dissolves in urine and is responsible for the yellow colour 
of urine.,but the major route for excretion is more complex.  
Amines:  
  Amines are a class of compounds derived from ammonia by replacement of one or 
more effective antagonists of SSTR5 (Stomatostatin receptor 5)and are used for 
treatment, control and prevention of disorders such as Type 2 Diabetes, insulin resistance, 
lipid disorders and obesity.  
Esters:  
  Esters are organic compound formed when an acid combine with an alcohol and 
release water.  Astringent . 
Alcohols: 
  Has anti microbial action.Acts as a antiseptic agent. 
Aromatics:  
  Aromatics are good pain relievers.Has Anti-pyretic, Anti-inflammatory, Auto-
immune activities. 
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ICP-OES of KATTUVAI MATHIRAI 
 
Kattuvai Mathirai  (wt:0.41210g) 
 
Elements Wavelength 
(nm) 
Concentration 
Al 396.152 BDL 
As 188.979 BDL 
Ca 315.807 32.354 mg/l 
Cd 228.802 BDL 
Cu 327.393 BDL 
Fe 238.204 32.354 mg/l 
Hg 253.652 BDL 
K 766.491 23.171 mg/l 
Mg 285.213 01.784 mg/l 
Na 589.592 42.280 mg/l 
Ni 231.604 BDL 
Pb 220.353 BDL 
P 213.617 116.227 mg/l 
S 180.731 31.324 mg/l 
Zn 206.200 01.216 mg/l 
 
BDL: Below Detectable Limit(Normal-1ppm) 
     1%  = 10000ppm, 
     1ppm = 1/1000000 or 0.0001% 
Toxic metals and the permissible limits 
 
Heavy metals WHO & FDA limits 
Arsenic(As) 10ppm 
Mercury(Hg) 1ppm 
Lead (pb) 10ppm 
Cadmium (Cd) 0.3ppm 
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Result 
   The result indicate that the formulation is extremely safe as it contains heavy 
metals within specified limits.  
1. ICP-OES reveals high concentration of  K in Kattuvai Mathirai 23.171mg/L. 
2. Concentration of  Na is 42.280 mg/L, phosphorous is 116.227 mg/L  
3. It also has physiologically important minerals like Na, K,P. Ca. 
  Below detection limit(BDL) of heavy metals As(arsenic), Hg(Mercury), Cd 
(Cadmium), Pb(Lead), Cu (Copper) and trace elements like  Ni(Nikkal), Al(Aluminum) is 
seen. 
 
INTERPRETATION 
  The result indicates the presence of pottassium, sodium, phosphorus, sulphate , 
zinc, iron, calcium, magnesium, phosporus 
• In the presence of sodium and pottassium,  these two elements are required 
for the regulation of acid base balance and water balance in the cells. 
• Calcium participated in several reaction in cascade of blood clotting process. 
• Phosphorus is important for the maintenance of pH in the blood as well as in 
the cells. 
• Zinc is a micro nutrient and is required for wound healing.Zinc has effects 
against viruses. {Rhino virus}.Zinc may be regarded as an antioxidant, 
protects the body against free radical damage and cell damage. Zinc is 
important for a healthy immune system. It enhances absorbtion of iron.It can 
produce healthy veins and arteries that enhance the blood circulation 
• Magnesium is a cofactor that regulates diverse biochemical reactions in the 
body, including protein synthesis, muscle, nerve function, blood glucose 
control and blood pressure regulation 
• Sulphate Sulphate may prevent the occurrence of any infection,Sulphate is 
potent anti oxidant activity in human body 
  This reveals the safety of the drug.It is evident that the effectiveness of Siddha 
medicine has been proved by the modern scientific way. 
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XRD (X-Ray Diffraction) 
   X-Ray powder diffraction is a rapid analytical technique primarily used for 
phase identification of a crystalline material and can provide information on unit cell 
dimensions.  
Fig. No. 8 XRD –Results of  KM 
 
  This XRD finger print shows both the similarities and differences of the sample 
successfully and is a valuable primary tool for checking the quality control of Herbo-
mineral formulations. The different peaks show the presence of minerals in the samples. 
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TOXICITY STUDIES 
8. EVALUATION OF ACUTE TOXICITY STUDY OF KATTUVAI MATHIRAI 
Effect of Acute Toxicity Study (14 Days) of kattuvai mathirai 
Table no 8.1   Physical and behavioral examinations. 
Group 
no. 
Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
Table no 8.2.    Home cage activity 
Functional 
and 
Behavioural 
observation 
Observation 
5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral 
closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch 
response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
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Table no 8.3  Hand  held  observation 
Functional 
and 
Behavioral 
observation 
Observat
ion 
Cont
rol 
5 
mg/ 
kg 
(G-I) 
50 
mg/k
g 
(G-
II) 
300mg/
kg 
(G-III) 
1000mg
/kg 
(G-IV) 
2000mg
/kg 
(G-V) 
Fema
le 
n=3 
Fem
ale 
n=3 
Fem
ale 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdominal 
tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
Table no 8.4   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
  From acute toxicity study it was observed that the administration of KATTUVAI 
MATHIRAIat a dose of 2000 mg/kg to the rats do not produce drug-related toxicity and 
mortality. So No-Observed-Adverse-Effect- Level (NOAEL) of KATTUVAI 
MATHIRAIis 2000 mg/kg. 
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DISCUSSION 
  kattuvai mathirai was administered single time at the dose of 5mg/kg, 
50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for consecutive 
14 days after administration. Doses were selected based on the pilot study and 
literature review. All animals were observed daily once for any abnormal clinical signs. 
Weekly body weight and food consumption were recorded. No mortality was observed 
during the entire period of the study. Data obtained in this study indicated no 
significance physical and behavioural signs of any toxicity due to administration of 
kattuvai mathirai at the doses of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 
2000mg/kg to rats.  
  At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, 
Lacrimation, Salivation, Piloerection, Papillary reflex, abdominaltone, Limb tone were 
observed. Functional and behavioral examination was normal in all treated 
groups.Food consumption of all treated animals was found normal as compared to 
normalgroup. 
  Body weight at weekly interval was measured to find out the effect of kattuvai 
mathirai on the growth rate. Body weight change in drug treated animals was found 
normal. 
 
INTERPRETATION: 
 
 kattuvai mathirai was administered single time at the dose of 5mg/kg, 
50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for consecutive 
14 days after administration. Doses were selected based on the pilot study and 
literature review. All animals were observed daily once for any abnormal clinical signs. 
Weekly body weight and food consumption were recorded. No mortality was observed 
during the entire period of the study. Data obtained in this study indicated no 
significance physical and behavioural signs of any toxicity due to administration of 
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KATTUVAI MATHIRAI at the doses of 5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg 
and 2000mg/kg to rats.  
At the 14th day, all animals were observed for functional and behavioral examination. 
In functional and behavioral examination, home cage activity, hand held activity were 
observed. Home cage activities like Body position, Respiration, Clonic involuntary 
movement, Tonic involuntary movement, Palpebral closure, Approach response, 
Touch response, Pinna reflex, Sound responses, Tail pinch response were observed. 
Handheld activities like Reactivity, Handling, Palpebral closure, Lacrimation, 
Salivation, Piloerection, Papillary reflex, abdominaltone, Limb tone were observed. 
Functional and behavioral examination was normal in all treated groups.Food 
consumption of all treated animals was found normal as compared to normalgroup. 
Body weight at weekly interval was measured to find out the effect of kattuvai 
mathirai on the growth rate. Body weight change in drug treated animals was found 
normal. 
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9. SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF KATTUVAI MATHIRAI 
Table :9.1 EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF KATTUVAI 
MATHIRAION BODY WEIGHT IN GRAM 
GROUP CONTROL LOW  MID HIGH 
1
st
 day 122.3±1.23 125±1.743 124.3±2.431 126.3±2.43 
7
th
 day 132.3±1.23 131.3±1.543 131±2.313 137±2.31 
14
th
 day 134.1±1.204 102.3±1.32 102.4±2.212 103.4±2.212 
21
st
 day 103.3±2.320 110.2±1.701 104±1.331 105±1.33 
28
th
 day 113.3±1.241 112.3±1.402 143±2.2405 146±2.240 
 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group. 
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EFFECT OF SUBACUTE DOSE (28 DAYS)OF kattuvai mathirai  
Table : 9.2. kattuvai mathirai ON ORGAN WEIGHT (PHYSICAL 
PARAMETER) IN GRAM 
GROUP CONTROL LOW  MID HIGH 
HEART 0.43±0.04 0.24±0.06 1.01±0.31 0.41±0.04 
LIVER 2.31± 0.43 4.33±0.43 2.20±0.03 2.23± 0.43 
LUNGS 1.31±0.30 0.31±0.34 0.50±0.44 1.43±0.30 
KIDNEY L 0.43±0.04 1.52±0.05 0.43±0.04 0.41±0.04 
 R 0.41±0.044 1.14±0.04 0.41±0.044 0.42±0.044 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KATTUVAI MATHIRAI ON 
HAEMATOLOGICAL PARAMETERS 
Table no 9.3 
Drug 
treatm
ent 
RBC 
million 
cells/c
mm 
WBC  
cells/cmm 
Haemoglo
bin gm % 
Differen
tial 
count % 
   
    Neutrop
hils 
Eosinop
hils 
Monoc
yte 
Lymphoc
yte 
Control 5.21±0.
60 
5252.41±4
3.32 
12.40±0.6
5 
31.27±1.
40 
3.53±0.3
1 
0.65±0.
35 
23.13±3.
52 
LOW  3.47±0.
40 
4334.04±4
3.22 
7.20±0.63 25.54±1.
61 
2.10±0.3
4 
.02±0.5
0 
23.22±3.
51 
MID 4.33±0.
41 
4304.25±5
2.35 
14.11±3.0
3 
30.32±2.
42 
3.44±0.3
2 
0.62±0.
60 
23.13±3.
52 
HIGH 5.26±0.
41 
4588.25±5
2.35 
16.11±3.0
3 
28.32±2.
42 
3.50±0.3
2 
0.64±0.
60 
24.13±3.
52 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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Table :9.4  EFFECT OF SUB- ACUTE DOSE(28 DAYS)OF KATTUVAI 
MATHIRAION BIOCHEMICAL PARAMETERS 
 
 
Drug 
Treatment 
SGPT 
(IU/L) 
SGOT(IU/L) ALP(IU/L) Urea 
(mg/dl) 
Creatinine(mg/dl) 
Control 52.14±3.22 42.24±4.51 243.12±13.32 35.35±3.20 0.54±0.05 
      LOW 42.13±3.42 41.23±4.21 251.11±14.42 40.53±2.62 0.50±0.06 
MID 50.21±4.64 44.31±2.41 245.45±4.34 39.12±2.42 0.45±0.06 
HIGH 52.21±4.64 40.31±2.41 234.45±4.34 40.12±2.42 0.46±0.06 
 
 
 
 
 
  
0
10
20
30
40
50
60
Control KM200 mg/kg KM400 mg/kg KM 600 mg/kg
SGPT (IU/L)
SGOT (IU/L)
225
230
235
240
245
250
255
Control KM200 mg/kg KM400 mg/kg KM 600 mg/kg
ALP (IU/L)
  
   140 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
 
 
 
 
 
 
  
32
33
34
35
36
37
38
39
40
41
Control KM200 mg/kg KM400 mg/kg KM 600 mg/kg
Urea
32
33
34
35
36
37
38
39
40
41
Control KM200 mg/kg KM400 mg/kg KM 600 mg/kg
Creatinine
  
   141 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KATTUVAI MATHIRAI 
BIOCHEMICAL PARAMETERS 
 
GROUP CONTROL 
 kattuvai 
mathirai 
(200mg/kg) 
kattuvai 
mathirai 
(400mg/kg) 
 kattuvai 
mathirai 
(600mg/kg) 
TOTAL 
BILIRUBIN 
(mg/dl) 
1.308±0.2457 1.458±0.2827 0.8198±0.3376 0.104±0.199 
  
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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Table: 9.5 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OFON FOOD INTAKE 
IN GRAM 
GROUP CONTROL kattuvai 
mathirai 
(200mg/kg) 
kattuvai 
mathirai 
(400mg/kg) 
kattuvai 
mathirai 
(600mg/kg) 
1st DAY 19.33±15.6110 20.1672±17.3 13.10±24.71 18.5±8.82 
7th DAY 16.5±14 11.863±15.67 17.73±12.853 12.17±17.41 
14th DAY 19.83±8.92 11.83±17.28 11±16.96 20.72±11.981 
21st DAY 12.87±15.4 16±8.678 16.88±12.43 20.17±9.22 
28th DAY 13.10±13.38 19.38±13.50 11±10.90 11±7.77 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group 
 
 
 
 
 
  
0
5
10
15
20
25
1st day 7th day 14th day 21st day 28th day
FOOD INTAKE
CONTROL
KM200mgmg/kg
KM400mgmg/kg
KM600mgmg/kg
  
   143 PRE CLINICAL  STUDY OF  KATTUVAI  MATHIRAI 
 
Table: 9.6 Effect of Sub- Acute Dose (28 Days) Of  KATTUVAI MATHIRAIOn 
Water Intake in ml 
GROUP CONTROL kattuvai 
mathirai 
(200mg/kg) 
kattuvai 
mathirai 
(400mg/kg) 
kattuvai 
mathirai 
(600mg/kg) 
1st DAY 
97.38±13.50 89.12±14.34 102.10±21.719 67.5±7.63 
7th DAY 
85.5±11.79 100.83±12.60 76.73±9.83 81.17±14.0 
14th 
DAY 58.33±8.717 90.83±14.12 80±13.96 89.162±8.81 
21st DAY 
91.67±12.49 85±8.42 65.38±9.40 89.17±8.62 
28th 
DAY 82.10±11.40 88.38±11.54 80±8.61 70±7.53 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group 
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Table: 9.7.  EFFECT OF SUB ACUTE DOSES (28 DAY) OF KATTUVAI 
MATHIRAION ELECTROLYTES: - 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s(n=6); NS- non-significant, *p<0.05, **p<0.01, 
***p<0.001,  
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kattuvai 
mathirai 
(200mg/kg) 
kattuvai 
mathirai  
(400mg/kg) 
kattuvai 
mathirai 
(600mg/kg) 
Sodium (mg/dl) 
134.10±0.55 144.30±0.62 141±0.71 141.80±0.70 
Calcium(mg/dl) 12.50±0.19 13.20±0.13 14.7±0.19* 16.80±0.111 
Phosphorus 
(U/L) 9.278±0.7 8.3010±0.0ns 8.30±0.91ns 8.037±0.02* 
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6.0 RESULTS: 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   period 
of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the dosing 
period of 28 days. 
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 Body weight: 
Results of body weight determination of animals from control and different dose 
groups exhibited comparable body weight gain throughout the dosing period of 28 
days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food consumed by 
animals from different dose groups was found to be comparable with that by control 
animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in Table No.9.1 
Comparison of organ weights of treated animals with respective control animals on day 
29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations conducted on day 29 revealed following 
significant changes in the values of different parameters investigated when compared 
with those of respective controls; however, the increase or decrease in the values 
obtained was within normal biological and laboratory limits or the effect was not dose 
dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on the day 29th and recorded in Table 
no 9.4 revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and laboratory 
limits. 
 
 
INTERPRETATION: 
1)  All the animals from control and all the treated dose groups up to 15ml/kg survived 
throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
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4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29th, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29th, no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found to 
be comparable with that of respective controls. 
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PHARMACOLOGICAL RESULTS 
 
ANTI DIARRHOEAL ACTIVITY 
Table  : 10  EFFECT OF KATTUVAI MATHIRAI ON CASTOR OIL - INDUCED 
SMALL INTESTINAL TRANSIT IN RATS 
 
GROUP 
 
Total Length of 
Intestine 
 
Distance Travelled 
By Marker 
CHARCOAL 
 
 
%Intestinal 
Transit 
 
Control saline (2ml/kg i.p) 90.4±1.3267 0±0 ----- 
Castor oil (1ml p.o) 
+charcoal meal (1ml p.o) 
78.4±3.9192 65±2.68328 28.09 % 
Castor oil (1ml p.o) 
+Atropine (3mg/kg i.p) 
85.4±2.2271 46.6±10.1025 40.56 % 
Castor oil (1ml p.o) + KM 
100mg/kg  
79.2±3.7336 49.8±7.90822 36.31 % 
Castor oil (1ml p.o) + KM 
200mg/kg 
81.8±4.1761 41.6±7.11056 47.47 % 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated by one way 
ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
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Figure No.9  Effect of Kattuvai Mathirai on castor oil – induced small intestinal 
transit in rats. 
 
Interpretation 
  The Anti-diarrhoeal activity of siddha formulation Kattuvai Mathirai at 100mg/kg 
were tested for their anti-diarrhoeal activity by using caster oil – induced small intestinal 
transit in rats and the result are tabulated in table no.10.  The results reveals that 
100mg/kg  & 200mg/kg dose of siddha preparation of Kattuvai Mathirai posseses 
signification anti-diarrhoeal activity when compared to control group. 
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ANTI-PYRETIC ACTIVITY  
TABLE NO : 11 EFFECT OF KATTUVAI MATHIRAI 
ON BEWER’S YEAST INDUCED PYREXIA IN RATS 
GPS Control Only yeast 
yeast + 
paracetamol 
(250mg) 
Yeast+  KM 
100mg/kg 
Yeast + KM 
200mg/kg 
Initial rectal 
temperature       
0hr 58.6±16.720 59.6±18.814 
58.8332±18.634
2 
59.6±18.9276 
60.8332±19.308
9 
Rectal 
temperature after 
induction with 
yeast 18hr 
57.5±16.520 78.8664±25.0262 
86.1832±27.403
2 
79.6832±25.282
4 
80.6665±25.646
2 
1st hr. 
56.5±15.700 84.9666±26.9435 89.1±28.3478 
82.7832±26.295
6 
83.6832±26.602
8 
 2nd hr. 
58.3±15.700 81.9832±25.9935 
85.8168±27.176
8 
78.3668±24.839
3 
76.9832±24.468
3 
 3rd hr. 
56.30±32.50 80.2332±25.3776 78.8832±25.007 
76.2334±24.144
2 
74.5±23.6679 
 4th hr. 
56.50±45.92 81.2±25.8892 77.35±24.4649 73.3168±23.235 
72.7668±23.129
8 
 5th hr. 
57.25±58.30 80.34±25.4612 72.05±22.806 
68.6332±21.731
2 
68.2165±21.627
6 
 6th hr. 52.50±12.20 80.1332±25.3455 62.74±19.8826 65.1±20.5935 63.64±20.1535 
 
I-control (Distilled water-1ml),II-(yeast-10ml),   III- Standard (Paracetamol l50mg), IV-
yeast10 ml with (KM-100mg),V-Yeast 10ml with KM 200mg.*Significant activity 
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Figure no : 10 Effect of KM on Brewer’s Yeast induced pyrexia in rats 
 
Interpretation :  
The results are prescribed in table no 11. Group V(KM) showed decrease in rectal 
temperature after 6 hours when compared to the standard drug. So  The test drug 
“Kattuvai Mathirai” has got significant anti-pyretic activity. 
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ANTI-SPASMODIC ACTIVITY (Smooth muscle relaxant)  
EFFECT OF KATTUVAI MATHIRAI ON EXCISED  
GUINEA PIG ILEUM (IN-VITRO) 
Dose Response Relationship Observations of Acetylcholine 
Table No: 12 
Sl.No Concentration/dose Acetylcholine 
Response (cm) 
1 0.1 ml 2.8 cm 
2 0.2 ml 3.0 cm 
3 0.4 ml 3.2 cm 
4 0.8 ml 4.0 cm 
5 1.6 ml 5.0 cm 
 
Dose Response Relationship Observations of Atropine 
Table No: 13 
Sl.No Concentration/dose atropine 
Response (cm) 
1 0.1 ml - 
2 0.2 ml - 
3 0.4 ml - 
4 0.8 ml - 
5 1.6 ml - 
 
Dose Response Relationship Observations of Acetylcholine and KATTUVAI 
MATHIRAI 
Table No: 14 
Sl.No Concentration/dose Acetylcholine + KATTUVAI 
MATHIRAI 
Response (cm) 
1 0.1 ml +0.1 ml 3.6 cm 
2 0.2 ml +0.2 ml 4.0 cm 
3 0.4 ml +0.4 ml 4.6 cm 
4 0.8 ml +0.8 ml 5.0 cm 
5 1.6 ml + 1.6 ml 6.3 cm 
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Comparative Dose Response of Acetylcholine followed by KATTUVAI MATHIRAI 
Table No: 15 
Sl. No Treatment  Dose(ml) response 
1  
Acetylcholine 
0.1 ml 2.8 cm 
2 0.2 ml 3.0 cm 
3 0.4 ml 3.2 cm 
4 0.8 ml 4.0 cm 
5 1.6 ml 5.0 cm 
6  
Acetylcholine  +KATTUVAI 
MATHIRAI 
0.1 ml+0.1 ml 3.6 cm 
7 0.2 ml+0.2 ml 4.0 cm 
8 0.4 ml+0.4 ml 4.6 cm 
9 0.8 ml+0.8 ml 5.0 cm 
10 1.6 ml+1.6 ml 6.3 cm 
 
 
Fig: 11. Comparative dose response relationship of Acetylcholine andKATTUVAI 
MATHIRAIon excised rat ileum. 
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RESULTS:-  
 Effect of Acetylcholine on excised rat ileum reflected an increase in spasmodic 
activity (response) with an increase in dose. 
INTERPRETATION: 
             From the present study results it was observed that acetylcholine (Ach) alone 
causes contraction of excised rat ileum but when acetylcholine was given in presence of 
KATTUVAI MATHIRAIthere was a marked decrease in contraction of ileum was 
observed. This revealed that KATTUVAI MATHIRAIpossess a high degree of anti-
spasmodic (smooth muscle relaxant)  activity by blocking cholinergic receptors. 
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ANTIMICROBIAL ACTIVITIES  
Table 16. Antimicrobial Activities of Drug by Agar Well Diffusion Method 
S.No. Test Pathogens Result  Zone of Inhibition (mm) 
Positive Control 
(Gentamycin)  
Size of  
Inhibition 
1. Escherichia coli Sensitive  20 mm 11 mm 
2 Klebsiella pneumoniae Sensitive 22 mm 13 mm 
3 Staphylococcus aureus Sensitive  21 mm 16 mm 
4 Pseudomonas aeruginosa Sensitive 22 mm 15 mm 
5. Salmonella typhi Sensitive 19 mm 19 mm  
 
FIGURE 12 :  ANTI-MICROBIAL ACTIVITY RESULT 
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INTERPRETATION 
Thus, the present study proves that Kattuvai Mathirai  is free from microbial 
contamination and also highlighted the safety of the same. The information obtained from 
microbial screening tests will be use full in finding out the quality of the drug 
 The good antibacterial activity of herbal medicines implies that the antimicrobial 
compounds present in herbal medicines are possibly controlling the microbial activity. 
Herbal medicines Kattuvai Mathirai  showed varying degrees of in vitro antibacterial 
activity against test bacteria.  
Both Gram positive and Gram negative bacteria E.coli, Klebsiella pneumoniae 
Pseudomonas aeruginosa and Salmonella sp and Staphylococcus aureus were found to be 
sensitive to herbo mineral medicine.  
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7. SUMMARY 
 
According to siddha aspect, diarrhoea is produced by derangement of pitha and 
vatha humors. The astringent taste of test drug diminish the deranged pitha humor. 
Astringent taste  which possess the seetha veeriam, very much helpful to diminish the 
aggravated pitha humor. 
According to pancha poothic theory astringent taste is a combination of primitive 
elements prithivi and vaayu. The prithivi pootha have a character of stability, increasing 
consistency and vaayu has the character to produce dryness. These three characters very 
much useful to treat the diarrhoea by making formed stools. 
In conclusion, the present study of Kattuvai mathirai possess astringent, pungent, 
bitter tastes, seetha veeriam which in turn diminish aggravated pitha humor there by 
treating diarrhoea and pyrexia. 
The trial drug of Kattuvai Mathirai was selected from the siddha text Sikitcha 
Rathna Deepam Ennum Vaithiya Nool,  for its anti-diarrhoeal, anti-pyretic and anti-
spasmodic activity.   
The raw drugs Sathikkai, Sathipathiri, Kirmbu, Athividayam, Ilavampisin, 
Kaichukatty, Neermulli vidhai, lingam were purchased from authorized drug store in 
Nagercoil at Kanniyakumari district. The fresh vilva pazham were collected from 
Sivankovil at Tirunelveli. The fresh oomathai ilai were collected from college campus. 
All the above ingredients were identified and authenticated by experts of PG gunapadam 
department, Govt. Siddha Medical College, Palayamkottai, Tamil Nadu. 
Collection of relevant literature evidences used in the preparation of Kattuvai 
mathirai for the ingredients which claims supports area Anti-diarrhoeal, anti-pyretic, 
Anti-spasmodic activites. 
The pharmacological review were done to establish the different methodologies 
adopted in the preclinical evaluation of the test drug. 
Physico chemical and bio-chemical analysis shows the presence of sulphate, 
phosphate, ferrous iron and amino acids all the above minerals might be responsible for 
the effectiveness of the drug. 
The phytochemical analysis of Kattuvai mathirai shows alkaloids, saponins and 
tannins. 
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Regarding instrumental analysis, reveals presence of important minerals like 
sodium, magnesium, calcium, iron, chloride, phosphorus and zinc these minerals 
normalize the electrolytes which are cost in diarrhoea. 
o FTIR reveals presence of alcohols which has anti-septic activity. 
o ICP-OES analysis of these drug shows heavy metals like arsenic, 
cadmium, nickel, copper and lead are found in below detecting level.  The 
toxic metals are found in BDL.  It reveals the drug in safer for long term 
use. The phosphorus is involved in tissue repair and silicon reduce 
digestive disorders.  Sodium chloride regulates acid-base balance.  Zinc 
has got potent anti-microbial activity.   
o SEM photographs revealed that particles are spherical in shapes and sizes 
are in the range  from 1 µm to 5 µm.  The size of the particles enables 
better absorption.  Hence the bioavailability is increased and even a 
minimal dose yields better results. 
Acute and sub-acute toxicity were carried out in wister rats according to OECD 
guidelines (423).  This drug has no acute toxicity as there was no mortality seen sub-acute 
toxicity is carried by repeated dose of test drug for 28 days.  Mortality, the functional 
observations, haematological and bio-chemical investigations were done.  There were no 
significant changes in the bio-chemical and haematological profile.  So the toxicological 
study of these test drug, Kattuvai mathirai establish the safety of the drug for long time 
administration. 
In pharmacological studies, the anti-diarrhoeal activity is carried out in rats by 
using castor oil-induced method.  The test drug Kattuvai mathirai has significant anti-
diarrhoeal activity, which reveals the effectiveness of Kattuvai mathirai in treating 
diarrhoea. 
o The anti-pyretic activity of test drug Kattuvai mathirai carried out by using 
Brewer’s yeast induced method.  The drug Kattuvai mathirai showed 
potent anti-pyretic activity. 
o Anti-spasmodic activity of test drug Kattuvai mathirai carried out in 
isolated guinea pig ileum using student’s organ bath.  This study reveals 
moderate anti-spasmodic activity of Kattuvai mathirai. 
Anti-microbial study of the test drug carried out by Agar well-diffusion method.  
It is observed that Kattuvai mathirai is sensitive to Escherichia coli, klebsiella 
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pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, salmonella typhi.  These 
Kattuvai mathirai has significant anti-bacterial activity. 
Result and discussion gives the necessary and essential justification to prove the 
potency of test drug with the scientific validation.  Thus the herbo-mineral formulation 
Kattuvai mathirai is validated for its safety efficiency in the management of diarrhoea and 
it would be the way for a drug of choice. 
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8. CONCLUSION 
 
 The trial drug of Kattuvai Mathirai was selected for the elaborate study of its 
efficacy on bedhi, From the literature review physico-chemical, Biochemical, 
Phytochemical,  pharmacological, microbiological, instrumental analysis, it has been 
good, Anti-diarrhoeal, Anti-pyretic and Anti-spasmodic activity and hence be effective 
for bedhi (Diarrhoea). 
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9. FUTURE SCOPE 
 
 The active principle which is responsible for the activity has to be find out through 
modern scientific analysis having made up of tablet form.  Kattuvai mathirai is 
extraordinary promise for the prevention and treatment of bedhi.  Thus the ancient 
wisdom siddhars will remains as one important source of future medicine and 
therapeutics. 
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